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ABSTRACT 
Total synthesis of ht-13-A and ht-13-B, total synthesis of aurantioclavine, 
progress towards the synthesis of cycloclavine. 
Yilin Zhang 
    Total synthesis of tetracyclic indole alkaloid ht-13-A and ht-13-B has been 
accomplished from commercially available (S)-4-amino-2-hydroxybutyric acid and trans-
4-hydroxy-L-proline respectively. The key synthetic steps include an acyliminium ion
allylation, a Mitsunobu reaction, a palladium-catalyzed Stille-Kelly cross coupling 
reaction, and a carbon monoxide mediated palladium-catalyzed reductive N-
heterocyclization. The total synthesis of aurantioclavine has been studied. The synthesis 
commenced with 2-amino-3-nitrophenol. Key synthetic steps include a Stille coupling 
reaction, a Heck reaction, a Lewis acid mediated cyclization and a carbon monoxide 
mediated palladium-catalyzed reductive N-heterocyclization. In addition, the first 
asymmetric total synthesis of (+)-cycloclavine has been studied. Key synthetic steps 
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13
C NMR of 3-[2-(3-methoxycarbonylamino-1-methylene- 222 
                    propyl)-3-nitro-phenyl]-acrylic acid methyl ester (74) 
Figure 116: 
1
H NMR of 3-[3-(2-methoxycarbonylamino-ethyl)-1H- 223 
                    indol-4-yl]-acrylic acid methyl ester (75)  
Figure 117: 
13
C NMR of 3-[3-(2-methoxycarbonylamino-ethyl)-1H- 224 
                    indol-4-yl]-acrylic acid methyl ester (75) 
Figure 118: 
1
H NMR of {2-[4-(3-hydroxy-3-methyl-but-1-enyl)-1H- 225 
                    indol-3-yl]-ethyl}-carbamic acid methyl ester (61) 
Figure 119: 
13
C NMR of {2-[4-(3-hydroxy-3-methyl-but-1-enyl)-1H- 226 
                    indol-3-yl]-ethyl}-carbamic acid methyl ester (61) 
Figure 120: 
1
H NMR of acetic acid 1,4-dimethyl-2,5-dioxo-pyrrolidin- 227 
                    3-yl ester (86) 
Figure 121: 
1
H NMR of acetic acid 3-acetoxy-1,4-dimethyl-5-oxo- 228 
                    pyrrolidin-2-yl ester (82) 
Figure 122: 
1
H NMR of acetic acid 2-(2-bromo-allyl)-1,4-dimethyl- 229 
                    5-oxo-pyrrolidin-3-yl ester (81) 
Figure 123: 
13
C NMR of acetic acid 2-(2-bromo-allyl)-1,4-dimethyl- 230 
                    5-oxo-pyrrolidin-3-yl ester (81) 
Figure 124: 
1
H NMR of acetic acid 1,4-dimethyl-5-oxo-2-(2-trimethyl- 231 
                    stannanyl-allyl)-pyrrolidin-3-yl ester (87) 
Figure 125: 
1
H NMR of acetic acid 2-{2-[2-(4-methoxy-benzyloxy)- 232 
                    6-nitro-phenyl]-allyl}-1,4-dimethyl-5-oxo-pyrrolidin-3- 
                    yl ester (80) 
Figure 126: 
1
H NMR of 5-{2-[2-(4-methoxy-benzyloxy)-6-nitro-phenyl]- 233 
                    allylidene}-1,3-dimethyl-1,5-dihydro-pyrrol-2-one (89) 
Figure 127: 
1
H NMR of tricyclic compound 90 234 
Figure 128: 
1
H NMR of N-allyl-2-methyl-N-(1-phenyl-ethyl)- 235 
                    acrylamide (92) 
Figure 129: 
13
C NMR of N-allyl-2-methyl-N-(1-phenyl-ethyl)- 236 
xv  
                    acrylamide (92) 
Figure 130: 
1
H NMR of 3-methyl-1-(1-phenyl-ethyl)-1,5-dihydro-pyrrol- 237 
                    2-one (93) 
Figure 131: 
13
C NMR of 3-methyl-1-(1-phenyl-ethyl)-1,5-dihydro-pyrrol- 238 
                    2-one (93) 
Figure 132: 
1
H NMR of 5-hydroxy-3-methyl-1-(1-phenyl-ethyl)-1,5- 239 
                    dihydro-pyrrol-2-one (94) 
Figure 133: 
1
H NMR of 5-(2-bromo-allyl)-3-methyl-1-(1-phenyl-ethyl)- 240 
                    1,5-dihydro-pyrrol-2-one (95) 
Figure 134: 
13
C NMR of 5-(2-bromo-allyl)-3-methyl-1-(1-phenyl-ethyl)- 241 
                    1,5-dihydro-pyrrol-2-one (95) 
Figure 135: 
1
H NMR (65 oC) of 5-[2-(2-methoxymethoxy-6-nitro- 242 
                    phenyl)-allyl]-3-methyl-1-(1-phenyl-ethyl)-1,5-dihydro- 
                    pyrrol-2-one (96) 
Figure 136: 
1
H NMR (65 oC) of 5-[2-(2-hydroxy-6-nitro-phenyl)-allyl]-3- 243 
                    methyl-1-(1-phenyl-ethyl)-1,5-dihydro-pyrrol-2-one (97) 
Figure 137: 
1
H NMR (65 oC) of trifluoro-methanesulfonic acid 2-{1-[4- 244 
                    methyl-5-oxo-1-(1-phenyl-ethyl)-2,5-dihydro-1H-pyrrol-2- 




      Chapter 1 Total synthesis of ht-13-B 
 
A. Introduction 
Two unique tetracyclic indole alkaloids were isolated in 2000 from Streptomyces sp. 
(PA-48561) by Kamiguchi and Yasui1. The alkaloids were named ht-13-A and ht-13-B, 
and their structures were elucidated by 1H and 13C NMR, UV, IR, and LRMS analyses 
(Figure 1). The indoles showed an affinity for serotonin receptors so that they may be used 
in treatment of central nervous system diseases such as depression, neurosis, senility, and 
Parkinson’s disease. To the best of our knowledge, ht-13-A and ht-13-B are the only two 
examples of naturally occurring 3,4-oxepino-fused indoles and they haven’t been 
synthesized before. Since they have very similar structural skeletons to compounds we 
have previously synthesized, they were chosen as target molecules by our group. A 
general synthetic strategy toward 3,4-fused indole alkaloids developed by our group can 
be applied in this synthesis which includes a Heck coupling reaction and a carbon 
monoxide mediated palladium-catalyzed reductive N-heterocyclization. 









3,4-Fused indoles are usually prepared by the installation of additional ring(s) onto a 
preformed indole framework. Pertinent to the synthesis of ht-13-B, 3,4-oxepine-fused 
indoles have been prepared by intramolecular C−O coupling reactions at the 4-position of 
the indole skeleton via enolate O-arylation of a benzyne intermediate2, copper-catalyzed 
O-arylation of an alcohol3, and nucleophilic aromatic substitution of a 4-nitro group4.  












A handful of examples have been reported wherein both the 3,4-fused ring and the 
pyrrole ring were sequentially assembled onto a functionalized benzene ring. This 
includes an intramolecular variation of the Larock indole synthesis5,6 (Scheme 1) and an 
intramolecular Fischer indole synthesis (Scheme 2).7 In addition, interesting rhodium(III)-
catalyzed intramolecular amidoarylation and hydroarylation have recently been described 
3  
by three different research groups (Scheme 3).8 We have previously reported a sequential 
intramolecular Heck reaction and palladium-catalyzed N-heterocyclization sequence to 
afford 3,4-fused indoles, including a 3,4-oxepine-fused ring system (Scheme 4).9  





















B. Results and Discussion 
The sequence depicted in Scheme 4 forms the basis of the initial retrosynthetic analysis 
of ht-13-B (Scheme 5). Hydride reduction of an N-alkoxycarbonyl protecting group 
should furnish ht-13-B. The carbamate would serve both as a protecting group limiting 
undesired coordination to palladium in earlier steps and as a source of the N-methyl group 
found in ht-13-B. In line with Scheme 4, the pyrrole ring of the indole would be formed 
via a palladium-catalyzed N-heterocyclization in the presence of carbon monoxide.10 The 
pyrrolidine and benzene rings may be connected utilizing a Mitsunobu reaction of 2-
bromo-3-nitrophenol with the allyl-substituted N-protected pyrrolidine 4 (R = t-Bu). A 
trans configuration is expected after the Mitsunobu reaction. Compound 4 was thought to 
be derived from diastereoselective allylation of the pyrrolidine 1 via an acyliminium ion 
type intermediate. Finally, pyrrolidine 1 can be achieved from commercially available 


























Pyrrolidine 1 was prepared from commercially available trans-4-hydroxy-L-proline 
following the procedure by Tanaka and Sawanishi (Scheme 6).11 The synthesis of 
pyrrolidine 1 started with a methylation reaction of trans-4-hydroxy-L-proline using 
thionyl chloride in methanol. Protection of the amine and hydroxyl group with 
corresponding tert-butyloxycarbonyl (Boc) and tert-butyldimethylsilyl (TBS) group led 
to the formation of compound 3. Treating the newly formed 3 with sodium borohydride 
and lithium chloride provided the corresponding alcohol, which was converted to 
mesylate following standard procedure. The resulting mesylate was first reduced by 
lithium triethylborohydride and then oxidized using ruthenium oxide and sodium 
periodate to yield pyrrolidin-2-one 2. The carbonyl group in 2 was reduced by lithium 
6  
triethylborohydride and the resulting hydroxyl group was methylated using methyl iodide 
under basic condition to afford pyrrolidine 1.    












a Prepared by colleague Jeremiah Hubbard 
 
Recently, Hart and co-workers have reported a Lewis acid mediated allylation reaction 
from a related pyrrolidine (Scheme 7).12 They showed that the cis-isomer was the major 
product in this reaction probably due to the directing effect of the tert-
(butyldimethylsilyl)oxy (OTBS) group.   







According to Hart’s procedure, introduction of the allyl side chain was achieved using 
allyl trimethylsilane in the presence of titanium tetrachloride to afford 5 (Scheme 8).12 The 
Boc protecting group was unexpectedly removed during the course of the reaction prior to 
purification.13 In addition, the product mixture proved to be sensitive to purification by 
chromatography on silica gel. Compound 5 was obtained as a mixture of two inseparable 
diastereomers in an approximate 5:1 ratio. The stereochemistry of either isomer could not 
be confirmed at this point in the synthesis. However, the major isomer was expected, based 
on Hart’s results, to have a cis relationship between the allyl and the OTBS groups.11,12,14 





The pyrolidine nitrogen in compound 5 was reprotected using Boc2O to give 6 (Scheme 
9). We were unable to separate the isomers, and interpretation of the NMR spectra after 
chromatography was complicated not only by the presence of two diastereomers but also 
by the fact that each of the diastereomers exists as a mixture of amide bond rotamers. 
Removal of the tert-butyldimethylsilyl group using tetrabutylammonium fluoride (TBAF) 
afforded the diastereomeric compounds 7 and 8. Gratifyingly, the diastereomers were 
readily separated by chromatography on silica gel at this point in the synthesis. The cis 
stereochemistry between the allyl chain and OTBS group in compound 7 was established 
by nOe NMR experiments. In addition, executing the sequence from 1 to 7 and 8 without 
8  
purification of the intermediates gave a better overall yield.  





With cis-isomer 7 in hand, a Mitsunobu reaction was attempted in the next step. The 
Mitsunobu reaction was firstly reported by professor Oyo Mitsunobu in 1967.15 It has 
been used in the synthesis of a variety of substrates such as esters, ethers, etc. It has been 
widely applied to invert the stereochemistry of an existing stereocenters in many 
complicate molecules. 
 In this synthesis, a Mitsunobu reaction of major isomer 7 with 2-bromo-3-nitrophenol 
9 using triphenylphosphine and diisopropylazodicarboxylate (DIAD) gave the expected 
product 10 in 70 % isolated yield (Scheme 10). The inverted trans stereochemistry 
between the aryl ether and OTBS group was established by NOE NMR experiments. This 
in turn confirms the cis stereochemistry of major product 5 from the initial allylation 
reaction. 
The Heck reaction is one of the well-known coupling reactions used in preparation of 
functionalized aromatic species. In the next step, an intramolecular Heck reaction16 of 10 
gave only the 8-endo trig cyclization product 11 in low isolated yield.17,18 The expected 
7-exo trig cyclization to afford 12 was not observed by 1H NMR of the crude reaction 
mixture. Several additional catalyst systems were examined, all affording 8-endo product 
11 in similar or lower isolated yields. Although the tricyclic compound cannot be used in 
9  
the synthesis of ht-13-B, the trans stereochemistry of the pyrrolidine-oxepine ring fusion 
was confirmed by single crystal X-ray analysis of 11 (Figure 2). 















Considering the exclusive formation of 8-endo cyclization product 11 from the Heck 
reaction of 10, a different approach was needed for the preparation of key intermediate 
12. Palladium(0)-catalyzed intramolecular coupling reactions of substrates containing two 
separate electrophilic sites (e.g., a halide or triflate) both able to undergo oxidative 
addition have been reported. One such coupling is the Stille-Kelly reaction.19,20 In this 
reaction, one electrophilic site undergoes intermolecular palladium-catalyzed 
trialkylstannylation using hexaalkylditin followed by an intramolecular Kosugi-Migita-
Stille reaction. This one-pot coupling reaction has mostly been used for aryl-aryl 
couplings,20c,21 although coupling reactions of a few aryl electrophiles with vinyl 
triflates,20a,b,22 and a vinyl bromide with a vinyl triflate,20d have been reported. No aryl 
electrophile-vinyl bromide couplings have been reported to the best of our knowledge. In 
contrast to the Heck reaction, the ring size of the product depends on the position of the 
two electrophilic sites; thus, a halide on the internal alkene carbon of the allyl group of 
the pyrrolidine ring should give rise to a seven-membered ring with an exocyclic alkene 
(Scheme 11). 






The new cyclization precursor was prepared in a fashion similar to compound 10. In 
the Lewis acid mediated allylation reaction, an alternative allyl compound 13 was used 
11  
which was prepared from commercially available 2,3-dibromopropene according to the 
literature (Scheme 12).23   





Treatment of 1 with an excess of 2-bromo-2-propen-1-yltrimethylsilane 1323 in the 
presence of titanium tetrachloride afforded allylation product 14, again with the loss of 
the Boc protecting group (Scheme 13).24 In addition to 14, bicyclic compound 15 was also 
isolated as a mixture of diastereomers. Related bicyclic compounds have been reported 
from gold-catalyzed cyclizations between an N-Boc group and an alkyne25 or an allene.26 
Compound 14 was isolated as a 9:1 mixture of isomers after chromatography. The relative 
cis stereochemistry between the allyl and the OTBS groups of the major isomer of 14 was 
elucidated by double pulsed field gradient spin echo nuclear Overhauser effect (DPFGSE-
NOE) NMR experiments. It should be noted that the mixture of isomers could not be 
separated at any point in the synthesis prior to the final product. 






Other Lewis acids have been employed in reactions of acyliminium ion intermediates 
with nucleophiles. For example, no loss of the Boc group was observed using boron 
trifluoride diethyl etherate (BF3.OEt2) (Scheme 14).
14,27  








Thus, the reaction of 1 with 13 in the presence of BF3.OEt2 as the Lewis acid and the 
influence of the reaction temperature was briefly investigated (Table 1). Under an identical 
temperature profile as used for the reaction in the presence of titanium tetrachloride 
(TiCl4), an inferior yield of an inseparable mixture of isomeric 14 mixed with unknown 
side products was obtained (Table 1, entry 2). Treatment of 1 with 13 at -78 °C did not go 
to completion even after extended reaction times (Table 1, entry 3). In addition to a 
significant amount of starting material, a low yield of the allylated pyrrolidine 16 having 
an intact Boc group was isolated. Finally, all of the starting material was consumed at a 
higher reaction temperature (-30 °C), but the yield of 16 was still unsatisfactory (Table 1, 
13  
entry 4). As was the case employing TiCl4, a significant amount of bicyclic product 15 was 
also isolated. It was concluded that BF3.OEt2 did not significantly improve the outcome of 
the reaction. 






Purified amine 14 was re-protected as a methyl carbamate using methyl chloroformate 
to afford 14 (Scheme 15). A significantly higher overall yield of 14 from 1 was obtained 
without purification of crude 14 (55 % vs 23 %). Removal of the TBS group with TBAF 
gave compound 18. Mitsunobu reaction was attempted in next step. Treatment of 18 with 
2-bromo-3-nitrophenol 9 in the presence of 1.1 eq. of DIAD simply resulted in the recovery 
of starting material 18. To our delight,  the use of 4.0 eq. of DIAD in the Mitsunobu 
Entry Lewis acid Temperature Products (% isolated yield) 
1 TiCl4 -78 °C to r.t. 14 (56 %) 15 (30 %)  
2 BF3.OEt2 -78 °C to r.t. 14 (<41 %)
a 15 (trace)  
3 BF3.OEt2 -78 °C 1 (47 %)  16 (19 %) 
4 BF3.OEt2 -78 °C to -30 °C  15 (23 %) 16 (43 %) 
14  
reaction led to the formation of anticipated compound 19 in 66 % yield.  








Stille-Kelly reaction of 19 with hexamethylditin in the presence of a catalyst system 
consisting of bis(dibenzylidenacetone)palladium(0)-triphenylphosphine produced desired 
tricyclic compound 20 (Table 2, entry 2). Although the starting material was completely 
consumed, no other products were isolated. A few additional catalyst systems were 
examined in an attempt to improve the yield of the reaction. However, inferior results 
were obtained in all cases (Table 2). Considering the two active coupling sites exists in 
the starting material, we believe that polymerization may occur during the transformation 
which gave rise to uninterpretable byproducts and lowered the isolated yield of desired 
product.  Comparing all the conditions attempted, the Stille-Kelly reaction of 19 using 
PPh3 as the ligand in toluene at 140 °C provided the best isolated yield (44 %) (Table 2, 
entry 2). Lower temperature resulted only in decomposition or polymerization of the 
15  
starting material (Table 2, entry 1). Likewise, poor yield of desired product was obtained 
when other ligand-solvent systems were employed (Table 2, entry 3-6).    





Entry Ligand/Additive Solvent Temperature Time Yield 
1 PPh3 toluene 80 °C 3 h trace 
2 PPh3 toluene 140 °C 3 h 44 % 
3 AsPh3 toluene 140 °C 1.5 h 39 % 
4 PPh3 DMF 140 °C 3 h 33 % 
5 PPh3 dioxane 140 °C 5.5 h 38 % 
6 PPh3/CuI toluene 140 °C 7 h 21 % 
 
As an alternative to coupling of tin reagents, a boron variant wherein one of the halides 
is transformed to borate followed by intramolecular Suzuki coupling has been reported, 
for example, using bis(pinacolato)-diborane (Scheme 16).21,28 All attempted couplings of 
19 using the latter strategy were unsuccessful, resulting only in complete loss of starting 
16  
material and the formation of intractable products. 





The structure and relative stereochemistry of indole precursor 20 were confirmed by 
extensive NMR experiments and single crystal X-ray analysis (Figure 3).  





In the next step, the indole precursor 20 was subjected to a palladium-catalyzed 
reductive N-heterocyclization reaction developed by our group10. Utilizing this reaction, 
our group have accomplished the total synthesis of several indole natural products such 
as murrayaquinone A, clausenalene, and salviadione (Scheme 17). 









As expected, N-heterocyclization of 20 gave the tetracyclic indole 21, the immediate 
precursor to the alkaloid ht-13-B, as a single isomer (Scheme 18).  





Finally, the N-methoxycarbonyl protecting group of 21 was reduced to a methyl group 
using sodium bis(2-methoxyethoxy)aluminum hydride (Red-Al) in toluene at 110 °C to 
afford ht-13-B in high isolated yield (Scheme 19).29 Reduction of 21 using a large excess 
of lithium aluminum hydride (LAH) in refluxing tetrahydrofuran (THF) was also 
attempted; however, this only resulted in complete recovery of the starting material. 








The structure of the final product was elucidated by extensive NMR experiments and 
single crystal X-ray analysis (Figure 4). The NMR, IR, HRMS, melting point,30 and 
optical rotation were compared with literature data, which all corroborated the originally 
proposed structure. The overall yield of ht-13-B in seven steps starting from compound 1 























 An expedient synthesis corroborating the proposed structure of the tetracyclic indole 
alkaloid ht-13-B has been accomplished.31 Key synthetic steps include a Lewis acid 
mediated allylation, a Mitsunobu reaction, a palladium-catalyzed Stille-Kelly cross 
coupling reaction, and a carbon monoxide mediated palladium-catalyzed reductive N-



















Chapter 2 Total synthesis of ht-13-A 
 
A. Introduction 
 The indole alkaloid ht-13-A has one less methyl group than ht-13-B. It was the major 
biosynthetic product isolated from Streptomyces sp. (PA-48561) according to Kamiguchi 
and Yasui’s patent.1 In addition, the patent claims that ht-13-A is an important starting 
material for the synthesis of a variety of derivatives (Figure 5) which are believed to have 
significant biological activities. Therefore, the proposed total synthesis of ht-13-A offers 
an approach for its preparation, which would be significantly beneficial to the 




































B. Results and Discussions 
The retro-synthetic analysis of ht-13-A has been developed based on the synthetic 
strategy of ht-13-B (Scheme 20). The N-methyl group found in ht-13-A should be 
obtained from a hydride reduction of an N-alkoxycarbonyl protecting group. The 
palladium-catalyzed N-heterocyclization would build the desired indole core in ht-13-A. 
In our previous study, the 7-member ring in ht-13-B was successfully obtained via a Stille-
Kelly cross-coupling reaction, whereas, a Heck cross-coupling reaction only gave an 
unexpected 8-endo cyclization product (Scheme 10, Table 2). Thus, in the synthesis of ht-
13-A, the desired 7-exo trig cyclization product is expected after Stille-Kelly reaction. 
The benzene ring could be installed by a Mitsunobu reaction between 2-bromo-3-
nitrophenol and the allyl-substituted N-protected pyrrolidine 24. The pyrrolidine in turn 
could be prepared from diastereoselective allylation of the N,O-acetal species 23 which 
can be obtained from the known 2-pyrrolidinone 22. 











3(R)-t-Butyldimethylsilyloxypyrrolidin-2-one 2232 was prepared in four steps from 
commercially available 4-amino-2(S)-hydroxybutyric acid (Scheme 21). Thus, treatment 
of 4-amino-2(S)-hydroxybutyric acid with sulfuric acid in methanol followed by 
neutralization using potassium carbonate gave pyrrolidin-2-one 25. Compound 25 was 
converted to the benzoic acid ester via a Mitsunobu reaction. The stereochemistry was 
reversed in this transformation. Next, pyrrolidin-2-one 26, which has R-configuration at 
C-3, was formed by the saponification using potassium carbonate. The hydroxyl group 
was then protected as a TBS ether giving compound 22.33 The 3(R)-OTBS group in 22 
was anticipated to be the initial source of the two chiral centers of the target molecule.  








The nitrogen in pyrrolidin-2-one 22 was protected using di-tert-butyl dicarbonate 
(Scheme 22). Regioselective reduction by lithium triethylborohydride was observed at the 
carbonyl group on the pyrrolidinone ring of 27. The resulting hydroxyl group was 









In the next step, the allyl side chain was installed via the Lewis acid mediated allylation 
reaction. Two different Lewis acid, boron trifluoride diethyl etherate and titanium 
tetrachloride were examined in this reaction and the results were compared in Table 3. 
Treatment of 28 with BF3.OEt2 at -60 
oC gave the cis allylation product as the major 
product (dr = 6:1) without loss of the Boc protecting group (Table 3, entry 1). Herein, the 
stereoselectivity arose due to the directing effect of the OTBS group in 28. Meanwhile, 
the minor trans product was converted to a bicyclic compound 30 in the same 
transformation. No product was isolated wherein the Boc protecting group was lost during 
the reaction. When compound 28 was subjected to the TiCl4 condition (Table 3, entry 2), 
the Boc protecting group was removed and the allyl compound 31 was isolated in 50 % 
yield. Similar results was found in the synthesis of ht-13-B (Table 1). Compound 30 was 
isolated at the same time in 9 % yield as mixture of two diastereomers (dr = 9:1).  
In addition, an alternative synthetic pathway was attempted in order to compare with 
the results in Table 3 (Scheme 23). The N,O-acetal 28 was subjected to the TiCl4 mediated 
allylation to give 31, which was treated with methyl chloroformate and triethyl amine 
without further purification to afford methyl carbamate 32. The overall yield in two steps 
was 44 %.  
 
26  












Because BF3.OEt2 used in the allylation reaction gave only a moderate yield of tert-
butyl carbamate 29, and TiCl4 used in this reaction required extra synthetic step to re-
protect the amine group in the starting material, the synthetic route toward ht-13-A was 
modified at the early stage. In TiCl4 mediated allylation reaction, another common N-
Entry Lewis Acid Temperature Time 29 30 31 
1 BF3.OEt2 -60 
oC  1 h 40 % 





2 TiCl4  -78 
oC to r.t. -78 oC 15 min 
then r.t. 1 h 
none 9 % 
(dr = 12:1) 
50 % 
27  
protecting group, methyloxycarbonyl (Moc), exhibits excellent stability. Thus, the N-
protection of pyrrolidinone 22 using methyl chloroformate was performed following the 
standard procedure, giving methyl carbamate 33 in 79 % yield (Scheme 24).   











Regioselective reduction of 33 using lithium triethylborohydride gave the N,O-
hemiacetal 34 as an inseparable mixture of diastereomers. In our previous synthesis of ht-
13-B31, a related compound was initially O-methylated prior to a Lewis acid mediated 
allylation. However, in this synthesis, introduction of the allyl side chain via an 
acyliminium ion was achieved directly from 34. In the event, reaction of 34 with 2-bromo-
2-propen-1-yl trimethylsilane 1323 in the presence of an excess of titanium tetrachloride 
gave compound 32 as an approximately 6:1 mixture of two inseparable diastereomers. 
The major isomer was predicted to have a cis-relationship between the allyl and the OTBS 
groups based on literature precedence.11,12,13d, 24 However, the stereochemistry of either of 
28  
the isomer could not be confirmed at this point in the synthesis. The tert-
butyldimethylsilyl group was removed using tetrabutylammonium fluoride (TBAF) and 
at this point the diastereomers were readily separated by chromatography on silica gel 
affording pure pyrrolidines 35 and 36. The expected stereochemistry of the major isomer 
35 and the minor isomer 36 was cis and trans, respectively, as confirmed by nOe NMR 
experiments.   
Mitsunobu reaction of the major isomer 35 with 2-bromo-3-nitrophenol 9 in the 
presence of triphenylphosphine and diisopropylazodicarboxylate (DIAD) furnished 
compound 37 (Scheme 25). The expected cis to trans inversion of stereochemistry was 
again confirmed by nOe NMR experiments. With the correct stereochemistry established, 
two sequential palladium catalyzed reactions were employed to build the oxepane and 
pyrrole rings of ht-13-A. The oxepane was obtained using an intramolecular Stille-Kelly19 
reaction.  Compound 37 was treated with hexamethylditin in the presence of a catalyst 
system consisting of bis(dibenzylidenacetone)palladium-triphenylphosphine producing 
the tricyclic compound 38. All attempts to improve the yield of the coupling reaction from 
37 to 38, by modification of the catalyst system and the reaction conditions, failed to 
improve the yield. In addition to palladium based systems, bis(1,5-cyclooctadiene)nickel 
catalyzed intermolecular cross coupling reactions between aromatic bromides have 
recently been reported.34 However, the same catalyst system in this transformation only 
resulted in decomposition of the starting material to an intractable mixture. Palladium 
catalyzed reductive N-heterocyclization of 38 in the presence of carbon monoxide gave 
the expected tetracyclic indole 39.10 Finally, the methoxycarbonyl group was reduced to 
a methyl group using sodium bis(2-methoxyethoxy)aluminum hydride (Red-Al) in 
toluene affording ht-13-A in high isolated yield. The 1H and 13C NMR, IR, HRMS, 
29  
melting point and optical rotation data of synthetic ht-13-A were identical to the literature 
values of the compound isolated by Kamiguchi and Yasui.1 








In summary, a total synthesis of the tetracyclic indole alkaloid ht-13-A was 
achieved starting from commercially available (-)-4-amino-2-hydroxybutyric acid. 
The overall yield of ht-13-A in eight steps from pyrrolidinone 22 was 6 %. The trans 
stereochemistry was obtained from an acyliminium ion allylation followed by a 
Mitsunobu reaction. The 7-membered oxepane ring was obtained via an 
intramolecular Stille-Kelly reaction and the pyrrole ring was synthesized in a late 
stage carbon monoxide mediated palladium catalyzed reductive N-heterocyclization. 
This synthesis exemplifies a strategy for the synthesis of 3,4-fused indole alkaloids 


































Chapter 3 Total synthesis of aurantioclavine 
 
A. Introduction 
(-)-Aurantioclavine was firstly isolated from Penicillium aurantiovirens in 1981 by 
Kozlovskii and co-workers.35 (-)-Aurantioclavine is one of a number of 3,4-fused indole 
alkaloids containing a 7-membered azepino ring as well as a R chiral center (Figure 
6). It has been proven to be an important intermediate in the biosynthesis of communesin 
family natural products.  




After its discovery, several total synthesis pathways of this molecule have been 
designed.36 The first synthesis of aurantioclavine was reported by Hegedus and co-workers 
in 1987 (Scheme 26). In their synthetic strategy, the C-4 side chain was installed through 
a Heck coupling and then the 7-membered ring found in aurantioclavine was obtained 
via an acid-catalyzed intramolecular cyclization. Finally, the synthesis of 
aurantioclavine was completed after removal of a tosylate. The overall yield of 





Scheme 26 Hegedus’s synthesis of aurantioclavine 
 

















In 2010, Ellman and co-workers reported an asymmetric total synthesis of 
aurantioclavine starting with 4-bromotryptophol (Scheme 27). The chiral center was 
obtained from an asymmetric alkenylation of an N-tert-butanesulfinyl imine intermediate. 
The desired 7-member ring was built in the late stage via a basic substitution reaction.  






















In the same year, Jia and co-worker reported another asymmetric synthetic strategy 
toward (-)-aurantiocalvine (Scheme 28). The chiral center in the molecule was derived 
from methyl (S)-2-di-tert-butoxycarbonylamino-5-oxopentanoate. The structural skeleton 
of aurantioclavine was accomplished through a one pot Heck-aminocyclization reaction.  





















Recently, Takemoto’s group has developed a novel asymmetric allylic amination 
reaction to complete the synthesis of (-)-aurantiocalvine (Scheme 29). Using (S)-tBu-
PHOX as the chiral ligand in this reaction furnished the desired 7-member ring with 95 % 


































































B. Results and Discussions 
Most of the previous syntheses of aurantioclavine started with a preformed indole 
framework. It is essential to protect the nitrogen in the indole core to avoid side reactions 
and this requires additional synthetic steps. 
Herein, we present a shorter synthetic pathway to aurantioclavine (Scheme 30). 
Although a similar strategy as Takemoto’s was employed, our approach avoided the extra 
steps necessary in their synthesis to prepare the propenyl group and the indole core. The 
strategy proposed is as following. The indole core should be prepared from the palladium 
catalyzed N-heterocyclization of a nitrostyrene precursor. The 7-member azepino ring 
could be generated through a Lewis acid mediated intramolecular cyclization. The 
two side chains in intermediate 40 may be derived from nitrobenzene 41 via metal 
catalyzed cross-coupling reactions.  





























The synthesis commenced with installation of the side chains onto nitrobenzene 41 
via a regioselective Kosugi-Migta-Stille coupling reaction. Phenol 42 was firstly prepared 
from commercially available 2-bromophenol according to a literature procedure.37 
Treatment of 42 with triethylamine and trifluoromethanesulfonic anhydride in methylene 
chloride gave triflate 43 (Scheme 31), which was subsequently reacted with methyl 
carbamate 4438 prepared from 3-butyn-1-ol. This cross coupling reaction was carried out 
using a bis(triphenylphosphine)-palladium(II) dichloride and lithium chloride system. As 
expected, selective coupling at the OTf position was observed. Although the correct 
regioselectivity was established, the Heck precursor 45 was isolated in a relatively low 
yield (19%), which may be caused by the steric hindrance encountered at the OTf position.  





















Since a low yield was observed in the above coupling, an alternative pathway was 
investigated toward building block 45. The synthesis started with commercially available 
2-bromoaniline (Scheme 32). Protection of the amino group in 2-bromoaniline using 4-
toluenesulfonyl chloride (TsCl) gave tosylate 46. Based on a recently described nitration39, 
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46 was converted to nitrobenzene 47. Next, the tosyl group was removed using sulfuric 
acid and the resulting aniline 48 was transformed to 1-bromo-2-iodo-3-nitrobenzene 49 
by a Sandmeyer-type reaction. Arylstannane 50 was obtained from 49 using 
hexamethylditin. Finally, compound 50 was subjected to the Stille coupling condition with 
the known methyl carbamate 5138, however, an inferior yield of 45 was observed again.  




































Since all attempts to improve the yield of 45 were unsuccessful, the following work 
was focused on synthesis of a similar Heck precursor 53 (Scheme 33). Triflate 52 was 
prepared from 2-iodo-3-nitrophenol following the standard procedure. Kosugi-Migita-
Stille coupling using methyl carbamate 44 gave the desired Heck precursor 53. 
Unfortunately, the yield was still unsatisfactory. All efforts using selective Stille coupling 
reaction for the synthesis of the Heck precursors made no contribution to the improvement 
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of reaction yield. The reason might be the slow reaction rate of the transmetalation in Stille 
coupling due to a steric hindrance problem.    
















In addition, 2-iodo-3-nitrophenol was subjected to Stille coupling condition with 
methyl carbamate 44 (Scheme 34). Since the unprotected hydroxyl group may cause 
numerous side reactions, the desired phenol 54 was isolated in a low yield. 



















Considering the unsatisfactory yield of 54 found in the above coupling, a protecting 
group for the hydroxyl in 2-iodo-3-nitrophenol was introduced to avoid possible side 
reactions (Scheme 35).  Protection of the hydroxyl group using benzyl chloride and 
potassium carbonate gave nitrobenzene 55 in high yield. Compound 55 was transformed 
to arylstannane 56 using hexamethylditin in the presence of bis(triphenylphosphine) 
palladium dichloride. Pleasingly, the Stille coupling between 56 and methyl carbamate 51 
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successfully accomplished the desired 2-nitrostyrene 57 in good yield. As removal of the 
benzyl at this point may lead to a reduction of the vinyl group and unexpected loss of 
methyloxycarbonyl protecting group, 57 was transformed to indole 58 first under the N-
heterocyclization condition previously developed in our group.10 With indole 58 in hand, 
the reactions focused on functionalization of C-4 on the indole core were examined. The 
benzyl protecting group was smoothly removed using 10 wt.% palladium on carbon in the 
presence of hydrogen gas. An alternative deprotection was examined using palladium and 
ammonium formate in absolute ethanol, resulting in unexpected removal of the 
methyloxycarbonyl group. Next, 4-hydroxyindole 59 was converted to triflate 60. When 
methylene chloride was used as solvent in this transformation, extremely low yield was 
found probably due to the very low solubility of 59 in this solvent. Gratifyingly, using 
acetonitrile as solvent led to formation of triflate 60 in better yield. 



































We next turned attention to the construction of side chain at C-4 using a Heck reaction 
(Scheme 36). However, only a trace amount of product was found under various Heck 
conditions. The failure of those Heck coupling methods prompted us to pursue a synthesis 
of 61 to 2 steps, namely introducing a propargyl alcohol (62) which could be reduced to 
61. Unfortunately, no desired product 62 was formed under Sonogashira conditions.  


































As none of the coupling product was obtained from indole 60, we came back to the 
building block 53. Instead of using a benzyl protection approach, we anticipated that 4-
methoxybenzyl protection might give the desired building block 53 via a concise 
procedure (Scheme 37). Reaction of 2-iodo-3-nitrophenol with a mixture of 4-
methoxybenzyl chloride and potassium carbonate in refluxing acetonitrile gave 4-
methoxybenzyl phenyl ether 63. Arylstannane 64 was obtained when 63 was treated with 
bis(triphenylphosphine)palladium dichloride, hexamethylditin and triphenylphosphine in 
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refluxing toluene.  Reacting arylstannane 64 with methyl carbamate 51 under standard 
Kosugi-Migita-Stille conditions produced 65 in 81% yield. In order to selectively remove 
the 4-methoxylbenzyl protecting group, 65 was treated with 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) in refluxing chloroform. When this deprotection was performed at 
ambient temperature, none of desired 54, only starting material was recovered. 
Furthermore, the yield of 54 decreased significantly upon scaled-up of the reaction. Next, 
triflate 53 was easily obtained from 54 in 86% yield.   






































Because of the failure in the removal of PMB group in the scaled-up reaction, an 
alternative pathway to 54 has been studied (Scheme 38). Methoxymethyl phenyl ether 66 
was prepared by reacting 2-iodo-3-nitrophenol with chloromethyl methyl ether and 
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potassium carbonate in DMF at room temperature.  Under the same condition as described 
for the synthesis of compound 64, arylstannane 67 was obtained in 74% yield from 66. 
Through a Kosugi-Migita-Stille coupling, arylstannane 67 was converted to 2-nitrostyrene 
68. The latter successfully lost the methoxy methyl (MOM) protecting group using 
concentrated HCl in methanol. Gratifyingly, the scaled-up reaction from 68 to 54 was 
accomplished in a comparable yield. 




























In previous reactions, it was found that iodole 60 was unreactive under Heck reaction 
conditions. Therefore, 2-nitrostyrene 53 was examined as a possible substrate for the 
installation of C-4 side chain (Scheme 39).  As expected, compound 69 was readily obtained 
in 55% yield via the Heck reaction between triflate 53 and 2-methyl-3-buten-2-ol. Next, the 
indole core was successfully prepared through the N-heterocyclization reaction, whereas, 
dehydration occurred at the same time due to the harsh reaction condition, resulting in a 
formation of diene 70. To our delight, reduction of methyloxycarbonyl group in 70 using 
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sodium bis(2-methoxyethoxy)-aluminumhydride in reflux toluene formed another natural 
product, dehydrated ergotryptamine isolated in 2015 by Panaccione.39  
 

































As mentioned, the N-heterocyclization performed prior to the generation of 7-
membered azepino ring caused unexpected dehydration, therefore attempts were 
made to cyclize the 7-membered ring prior to indole formation. Treating compound 
69 with pyridinium p-toluenesulfonate (PPTS) in chloroform at 55 oC again resulted 
in dehydration affording product 71 (Scheme 40). Gratifyingly, the desired cyclization 
product 72 was formed when 69 was subjected to a Lewis acid (BF3.OEt2) in ether at 
ambient temperature (Scheme 41). The N-heterocyclization of 72 successfully furnished 














































Finally, the Moc deprotection of methyl carbamate 73 was attempted to finish the 
synthesis of aurantioclavine. As summarized in Table 4, several conditions were 
examined, however, no satisfactory results were obtained. Treatment of 73 with 
trimethylsilyl chloride with sodium iodide or trimethylsilyl iodide only caused 
decomposition of the starting material (Table 4, entry 1 and 2). When 73 was exposed to 
the condition in entry 3, only starting material was recovered because of the low solubility 
of 73 in methanol. The solubility of 73 was highly improved when 1-propanol was used 
as solvent in this reaction, however, no desired product was found either (Table 4, entry 
4). Other basic reagents including methyllithium and lithium triethylborohydride (Table 
4, entry 5-7) were tried in this reaction, but none of them afforded the desired product.  
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Entry Conditions Yield  
1 TMSCl, NaI, CH3CN, reflux, 2 h not observed 
2 TMSI, DCM, r.t., 2 h  not observed  
3 NaOH (3.0 M, aq.), MeOH, reflux, 12 h no reaction 
4 KOH (3.0 M, aq.), 1-Propanol, reflux, 2 days no reaction 
5 MeLi (1.6 M in ether), THF, 0 oC, 4 h  not observed 
6 LiEt3BH (1.0 M in THF, 3.0 eq.), THF, r.t., 3 days no reaction 
7 LiEt3BH (1.0 M in THF, 10.0 eq.), THF, 60 
oC, 9 h no reaction 
 
 
In addition to auratioclavine, triflate 53 was thought to be the precursor of another 
natural product, ergotryptamine.39 In three subsequent steps, triflate 53 was elaborated to 
indole 61 (scheme 42). First, Heck reaction of 53 with methyl acrylate gave 2-nitrostyrene 
74 in 61% yield. Next, the N-heterocyclization of 74 resulted in the formation of indole 
75 which was treated with methyl magnesium bromide in ether to afford indole 61. 
Eventually, the Moc protecting group in 61 was smoothly reduced to N-methyl group 
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using Red-Al at 50 oC. The 1H-NMR experiment of crude reaction mixture confirmed the 
formation of the desired ergotryptamine. However, the product was proved to be sensitive 
to purification by chromatography on silica gel. Other purification methods have been 
attempted, such as reversed phase chromatography, but no effective method has been 
developed to isolate pure ergotryptamine.  

























































C. Conclusions  
A concise total synthesis of aurantioclavine has been investigated starting from 2-iodo-
3-nitrophenol. Key steps include a Kosugi-Migita-Stille coupling reaction, a Heck 
coupling reaction, a Lewis acid mediated intramolecular cyclization and an N-
heterocyclization. The MOM group used in this synthesis as a protecting group 
successfully stabilized the phenol oxygen. The amine moiety was protected by a Moc 
group, however, no suitable condition for the Moc removal has been discovered. 
Meanwhile, the preparation of Heck precursor 45 and 53 utilizing selective Kosugi-
Migita-Stille coupling has been studied, but none of the attempts succeeded. Moreover, 
natural products ergotryptamine and dehydrated ergotryptamine have been achieved from 
the building block 53.  Development of a feasible purification procedure is necessary to 
isolate ergotryptamine in the future. In general, this work provides a novel strategy for the 


















Cycloclavine is one of the clavine-type ergot alkaloids initially isolated from African 
morning glory seeds (ipomoea hildebrandtii VATKE) by Hofmann and co-workers in 
1969.40 To the best of our knowledge, cycloclavine is the only example of ergot alkaloid 
containing a fused pentacyclic framework (Figure 7). Recently, O’Connor and co-workers 
have reported a biosynthetic pathway to cycloclavine from a common intermediate 
chanoclavine-I via an enzyme catalyzed rearrangement process.41 So far, cycloclavine has 
been synthesized by five research groups42 however, no asymmetric synthesis has been 
reported.   
Cycloclavine has three chiral centers at C-5, C-8 and C-10, a unique cyclopropane ring 
moiety, and a fused pentacyclic framework, which makes its synthesis very challenging, 
especially an asymmetric total synthesis.  






This chapter focus on the first asymmetric total synthesis of (+)-cycloclavine. We 
anticipated that the chirality at C-5 on cycloclavine could be achieved using the Lewis 
acid mediated allylation strategy applied in our previous syntheses31. Furthermore, the 
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pyrrolidine ring in cycloclavine could be produced following a similar synthetic route used 
in the synthesis of ht-13-A and ht-13-B. The indole core could be achieved in 2 steps 
including a Kosugi-Migita-Stille coupling and a N-heterocyclization in a late stage during 
the synthesis. A late formation of desired indole core will ensure a lower possibility of 
side reactions occurring in the early steps. Overall, the synthesis of cycloclavine is 
expected to be achieved via a short synthetic pathway based on our general strategy toward 

















B. Results and Discussions 
Based on our previous strategy for the synthesis of 3,4-fused indole alkaloid, 
retrosynthetic analysis of (-)-cycloclavine is described in Scheme 43. Cycloclavine could 
be prepared from a reduction of the carbonyl group in pyrrolidinone 76. The indole core 
would be obtained from the carbon monoxide mediated N-heterocyclization of 2-
nitrostyrene 77. Installation of cyclopropane ring onto -unsaturated amide 78 may 
furnished the tetracyclic intermediate 77. The middle 6-membered ring in 78 may be 
obtained from an intramolecular Heck reaction of triflate 79. The 1,5-dihydro-pyrrol-2-
one ring in 79 may be achieved via a base promoted elimination reaction of 80. In addition, 
deprotection of 4-methoxybenzyl group (PMB) followed by a reaction with Tf2O should 
give the desired trifluoromethanesulfonate group in 79. The benzene ring should be 
connected to the allyl side chain via a Kosugi-Migita-Stille coupling using the condition 
for the synthesis of 65 (Scheme 37). Compound 81 could be prepared from N,O-acetal 82 
through a Lewis acid mediated allylation. Finally, compound 82 was thought to be 
prepared from known compound 83 via three-step procedure including a reported 































 The synthesis began with the methylation of (S)-malic acid (Scheme 44). Treating (S)-
malic acid in refluxing methanol with concentrated HCl afforded ester 84. Compound 84 
was then exposed to lithium bis(trimethylsilyl)amide in THF to generate an enolate 
intermediate which reacted with methyl iodide to give ester 85 as a 15:1 mixture of two 
inseparable diastereomers. In the next step, hydrolysis of 85 using potassium hydroxide in 
a mixture of THF and methanol gave methyl malic acid 83, which was subsequently 
reacted with acetyl chloride and methylamine to form succinimide 86 with the same 
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diastereomeric ratio as 85. Gratifyingly, the regioselective reduction of 86 using sodium 
borohydride at -40 oC produced a N,O-hemiacetal intermediate as a single stereoisomer. 
Reduction of 86 at higher temperature (-20 oC to r.t.) resulted in a partial decomposition 
of the starting material as well as decreased diastereoselectivity. Acetylation of the 
remaining hydroxyl group was carried out to afford compound 82 in 42% yield (2 steps). 
The N,O-acetal moiety was activated by treating 82 with TiCl4 leading to the formation of 
an acyliminium ion intermediate. After addition of 2-bromo-2-propen-1-yl trimethylsilane 
13 to the reaction mixture, vinyl bromide 81 was formed as a single stereometric isomer 
in 94% yield. Replacement of the bromine in 81 by a trimethyltin group was readily 
achieved in the Pd(0)-hexamethylditin system giving trimethylstannane 87. Both 81 and 
87 can serve as starting materials for Kosugi-Migita-Stille coupling reaction in the next 
step.  











 We next focused on the Kosugi-Migita-Stille coupling reaction to connect the desired 
benzene ring to the pyrrolidin-2-one species (Scheme 45). The first attempt was made by 
reacting trimethylstannane 87 with 2-iodo-3-bromo-nitrobenzene 49, but target product 
88 was not observed. Likewise, reaction between vinyl bromide 81 and trimethylstannane 
50 gave no product. It is inferred that a steric hindrance problem might cause the failure 
of these two reactions. Nevertheless, compound 80 was successfully prepared by Kosugi-
Migita-Stille coupling reaction of 81 and 64.  
















 All attempted elimination reactions of 80 to build 1,5-dihydro-pyrrol-2-one moiety 
was unsuccessful and only two byproduct 89 and 90 were found (Scheme 46). A 
mechanism for this transformation was proposed. Treating compound 80 with 1,8-
diazabicycloundec-7-ene (DBU) led to the formation of an enolate, which rapidly oxidized 
when trace O2 remained in the system. Meanwhile, some of the enolates likely go through 
an intermolecular substitution reaction to afford spiro compound 90. The oxidized 
intermediate underwent a dehydration process in the basic environment and eventually 
generated compound 89. The elimination strategy used in this synthetic route resulted in 
a rapid deprotonation at C-5, which led to the formation of several byproducts and the loss 
of chirality.   










 Considering the unsuccessful elimination reaction in the previous synthetic route, an 
alternative pathway has been developed as described in Scheme 47. The synthesis 
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commenced with the preparation of amide 91 using commercially available methacryloyl 
chloride and (S)--methylbenzylamine. Allylation of 91 using sodium hydride and allyl 
bromide in DMF formed amide 92 which underwent ring closing metathesis with 1st 
generation Grubbs’s catalyst to provide 1,5-dihydro-pyrrol-2-one 93. Treatment of 93 
with lithium diisopropylamide (LDA) in THF delivered the enolate intermediate. The 
latter was oxidized by O2 to provide N,O-hemiacetal 94. A high concentration of O2 
proved to be critical for the production of 94 in high yield. Following the allylation of 94 
using TiCl4 and 2-bromo-2-propen-1-yl trimethylsilane 13, vinyl bromide 95 was obtained 
as a 3:1 mixture of two diastereomers. Compound 95 was converted into methoxymethyl 
phenyl ether 96 by Kosugi-Migita-Stille coupling.  After attempts under several reaction 
conditions, we found that the MOM group could be slowly removed from 96 by a complex 
of sodium bisulfate and silica gel44 forming phenol 97. Finally, 97 was treated with 



































The first asymmetric total synthesis of (+)-cycloclavine has been studied. The 1,5-
dihydro-pyrrol-2-one core was achieved early in the synthesis via the ring closing 
metathesis strategy. The C-5 chiral center has been successfully installed utilizing a Lewis 
acid mediated allylation. Introduction of the benzene ring was achieved by a following 
Stille coupling reaction. Eventually, this synthesis fulfilled the production of triflate 98, 
which is an important precursor of (+)-cycloclavine. 
Future effort will be focused on the study of intramolecular Heck cyclization reaction 





















Chapter 5 Experimental 
 
A. General Procedures 
 
All NMR spectra were recorded in CDCl3 at 600 MHz (
1H NMR) and 150 MHz (13C NMR, 
1H-broadband decoupled) at ambient temperature unless otherwise stated. Chemical shifts 
are expressed in δ values relative to Me4Si (0.0 ppm, 
1H and 13C) or CDCl3 (77.0 ppm, 
13C) 
internal standards. HRMS data were obtained via electrospray ionization (ESI) with an ion 
trap mass analyzer. THF was purified and dried via two consecutive columns composed of 
activated alumina and Q5 catalyst on a Glass Contours solvent purification system. 
Dichloromethane and toluene were purified and dried via two consecutive columns 
composed of activated alumina on a Glass Contours solvent purification system. Hexanes 
and ethyl acetate were distilled from calcium hydride. Chemicals prepared according to 
literature procedures are referenced the first time they are used in the Experimental Section; 
all other reagents were obtained from commercial sources and used as received. All 
reactions were performed under a nitrogen atmosphere in oven-dried glassware unless 
otherwise stated. Solvents were removed from reaction mixtures and products on a rotary 





A solution of 111 (762 mg, 2.21 mmol) and allyltrimethylsilane (1.40 mL, 8.81 mmol) in 
CH2Cl2 (10 mL) was cooled to -78 °C and stirred for 15 min. TiCl4 (490 μL, 4.46 mmol) 
dissolved in CH2Cl2 (5 mL) was slowly added via an addition funnel. The cold bath was 
removed after 5 min, and the mixture was stirred at ambient temperature for an additional 2 
h. The reaction mixture was poured into a slurry of Na2CO3·10H2O (6 g) in CH2Cl2 (7 mL). 
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After being stirred for 15 min, the mixture was dried (MgSO4) and filtered, and the solvent 
was removed to afford the crude mixture of isomeric 5 (511 mg). The product decomposed 
upon purification, and 5 was thus used as such to prepare 6. 
Spectral data from the 5:1 mixture of isomers of 5.  
Major isomer: 1H NMR (600 MHz, CDCl3) δ 5.82 (ddt, J = 16.8, 10.2, 6.6 Hz, 1H), 5.09 (d, 
J = 17.4 Hz, 1H), 5.02 (d, J = 10.2 Hz, 1H), 4.20 (br s, 1H), 3.58 (dt, J = 14.4, 7.2 Hz, 1H), 
3.13 (dt, J = 7.1, 3.4 Hz, 1H), 2.33 (pent, J = 6.6 Hz, 1H), 2.26 (pent, J = 7.2 Hz, 1H), 1.92 
(dd, J = 12.6, 6.6 Hz, 1H), 1.49 (ddd, J = 13.2, 9.0, 4.8 Hz, 1H), 1.18 (d, J = 6.6 Hz, 3H), 
0.88 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 136.0, 116.5, 73.9, 
62.9, 51.3, 43.8, 33.7, 25.8, 22.1, 18.0, -4.4, -5.0. 
Partial spectral data for the minor isomer of 5: 1H NMR (600 MHz, CDCl3) δ 3.87 (pent, J = 
4.2 Hz, 1H), 3.37 (ddd, J = 15.0, 12.6, 6.0 Hz, 2H), 2.95 (dt, J = 7.6, 5.3 Hz, 1H), 2.14 (pent, 
J = 7.4 Hz, 1H), 1.75 (ddd, J = 13.2, 6.6, 3.6 Hz, 1H), 1.15 (d, J = 6.6 Hz, 3H), 0.87 (s, 9H), 
0.03 (s, 3H), 0.03 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 135.7, 116.9, 67.0, 52.3, 43.5, 
38.3, 21.3, 18.0, -4.5, -4.7. 
 
1-(tert-Butoxycarbonyl)-3(R)-[(tert-butyldimethylsilyl)oxy]-5(R)-methyl-2-(2-propen-1-
yl)-pyrrolidine (6)  
To a suspension of 5 (511 mg, 2.00 mmol) and CH2Cl2 (5 mL) was added trimethylamine 
(0.84 mL, 6.03 mmol). The solution was cooled to -20 °C followed by addition of di-t-butyl 
dicarbonate (475 mg, 2.18 mmol), and the reaction mixture was stirred for 20 h slowly 
reaching ambient temperature. The reaction mixture was washed with H3PO4 (aqueous, 1 M, 
2x5 mL) and saturated NaHCO3 (aqueous, 2x5 mL). The organic phase was dried (MgSO4) 
and filtered, and the solvents were removed giving crude 6 (627 mg). The material was used 
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as such to prepare 7 and 8. In a separate experiment on an 8.21 mmol scale of 5, the crude 
product was purified by chromatography (hexanes/EtOAc, 1:1), affording a mixture of 
isomers used for characterization. 
Spectral data from the mixture for the major isomer/rotamer of 6: 1H NMR (600 MHz, 
CDCl3) δ 5.86 (pent, J = 8.0 Hz, 1H), 5.02 (d, J = 18.6 Hz, 1H), 4.95 (d, J = 9.6 Hz, 1H), 
4.45-4.43 (m, 1H), 4.03-3.76 (m, 2H), 2.61-2.49 (m, 1H), 2.26-2.24 (m, 1H), 1.93-2.08 (m, 
1H), 1.69-1.65 (m, 1H), 1.47 (s, 9H), 1.19 (d, J = 6.0 Hz, 3H), 0.90 (s, 9H), 0.07 (s, 6H). 
Partial spectral data for minor isomer/rotamer of 6: 1H NMR (600 MHz, CDCl3) δ 5.78 
(pent, J = 8.6 Hz, 1H), 1.45 (s, 9H), 1.15 (d, J = 6.0 Hz, 3H), 0.84 (s, 9H), 0.03 (s, 3H), 0.02 
(s, 3H). 
Spectral data for the mixture of both isomers of 6: 13C NMR (150 MHz, CDCl3) δ 154.0, 
146.7, 136.7, 136.5, 135.1, 116.9, 116.3, 85.1, 79.2, 78.9, 78.9, 70.8, 70.2, 67.2, 60.4, 60.1, 
52.4, 51.7, 50.6, 50.4, 40.0, 39.0, 33.7, 32.3, 28.6, 28.5, 27.4, 25.8, 25.7, 22.3, 21.2, 18.1, 
17.9, -4.9; IR (ATR) 2957, 2930, 1693, 1383 cm-1; HRMS (ESI) calcd for C19H37NNaO3Si 





To a 0 °C cold solution of 6 (626 mg, 1.76 mmol) in THF (10 mL) was added 
tetrabutylammonium fluoride (1.0 M in THF, 3.8 mL). The reaction mixture was stirred for 
26 h slowly allowing for the cold bath to reach ambient temperature. The reaction mixture 
was poured into H2O (50 mL) and extracted with EtOAc (4x25 mL). The combined organic 
phases were dried (MgSO4) and filtered, and the solvents were removed. Purification by 
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chromatography (hexanes/EtOAc, 7:3) gave 7 (286 mg, 1.18 mmol, 54 %) followed by 8 (56 
mg, 0.23 mmol, 11 %).45 
Spectral data of 7 as a mixture of rotamers at ambient temperature: 1H NMR (600 MHz, 
CDCl3) δ 5.95-5.88 (m, 1H), 5.10 (d, J = 17.4 Hz, 1H), 5.02 (d, J = 10.2 Hz, 1H), 4.54 (s, 
1H), 3.89 (br s, 2H), 2.91 (br s, 1H), 2.55 (s, 1H), 2.37 (s, 1H), 2.08-2.04 (m, 1H), 1.82-1.78 
(m, 1H), 1.47 (s, 9H), 1.19 (br s, 3H); 13C NMR (150 MHz, CDCl3) δ 154.0, 136.3, 116.5, 
79.3, 70.4, 70.1, 59.5, 50.5, 39.2, 38.2, 33.6, 32.3, 28.4, 21.8, 20.7; IR (ATR) 3436, 1663, 
1366, 1172, 1063 cm-1; [α]25D = -39.6 (c 1.02, CHCl3); HRMS (ESI) calcd for C13H24NO3 
(M+H+) 242.1756, found 242.1751. 
Partial spectral data for 7 as a mixture of rotamers at 60 °C: 1H NMR (600 MHz, CDCl3) δ 
5.91 (ddt, J = 17.4, 10.2, 7.2 Hz, 1H), 5.11 (dq, J = 17.4, 1.8 Hz, 1H), 5.02 (d with further 
fine splitting, J = 10.2 Hz, 1H), 4.51 (dt, J = 16.8, 7.2 Hz, 1H), 3.93 (br s, 1H), 3.87 (pent, J 
= 6.6 Hz, 1H), 2.54 (pent, J = 7.2 Hz, 1 Hz, 0.5H), 2.45 (br s, 1H), 2.21 (br s, 1H), 2.04 (ddt, 
J = 12.0, 10.8, 9.0 Hz, 1H), 1.79 (ddd, J = 12.0, 6.6, 1.8 Hz, 1H), 1.47 (s, 9H), 1.19 (d, J = 
6.0 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 154.1, 136.5, 129.9, 116.5, 79.3, 70.6, 59.7, 
50.7, 39.2, 33.0, 28.5, 28.4, 21.3. 
Spectral data for 8 as a mixture of rotamers at ambient temperature: 1H NMR (600 MHz, 
CDCl3) δ 5.77-5.84 (m, 1H), 5.09-5.06 (m, 2H), 4.11 (s, 1H), 4.00 (br s, 1H), 3.78 (s, 1H), 
2.42 (br s, 1H), 2.06-2.09 (m, 3H), 1.74-1.79 (m, 1H), 1.47 (s, 9H), 1.27 (br s, 3H); 13C 
NMR (150 MHz, CDCl3) δ 155.1, 134.8, 117.2, 79.3, 73.2, 66.8, 52.1, 40.6, 38.6, 28.5, 21.9; 
IR (ATR) 3405, 1664, 1390, 1169, 1096 cm-1; [α]25D = -8.1 ± 0.7 (c 5.75, MeOH); HRMS 
(ESI) calcd for C13H24NO3 (M+H
+) 242.1756, found 242.1751. 
Partial spectral data for 8 as a mixture of rotamers at 60 °C: 1H NMR (600 MHz, CDCl3) δ 
5.81 (ddt, J = 16.8, 10.2, 6.9 Hz, 1H), 5.09-5.05 (m, 2H), 4.11 (t, J = 1.2 Hz, 1H), 4.00 (q, J 
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= 6.6 Hz, 1H), 3.76 (br s, 1H), 2.44-2.42 (m, 1H), 2.09 (dt with further fine splitting, J = 
15.0, 7.8 Hz, 1H), 2.05 (dddd, J = 13.7, 7.4, 2.7, 1.3 Hz, 1H), 1.76 (ddd, J = 13.8, 8.4, 4.8 
Hz, 1H), 1.73 (br s, 1H), 1.47 (s, 9H), 1.26 (d, J = 6.6 Hz, 3H); Ambient temperature: 13C 
NMR (150 MHz, CDCl3) δ 155.1, 134.9, 117.1, 79.3, 73.7, 67.0, 52.3, 40.8, 38.6, 28.6, 22.1. 
 
2(R)-(2-Propen-1-yl)-1-(t-butoxycarbonyl)-3(S)-(2-bromo-3-nitrophenoxy-5(R)-methyl-
pyrrolidine (10)  
To a solution of 7 (423 mg, 1.75 mmol) in THF (5 mL) were added triphenylphosphine (690 
mg, 2.63 mmol) and 9 (574 mg, 2.63 mmol). The solution was cooled to 0 °C in an ice bath, 
and diisopropylazodicarboxylate (520 μL, 2.62 mmol) was added dropwise. The mixture 
was stirred at ambient temperature for 2 h. The solvent was removed, and the resulting 
mixture was diluted with CH2Cl2 (25 mL) and washed with saturated NaHCO3 (sat. aqueous, 
25 mL) and HCl (10 % aqueous, 25 mL). The organic phase was dried (MgSO4) and filtered, 
and the solvent was removed. Purification by chromatography (hexanes/EtOAc, 7:3) gave 10 
(542 mg, 1.23 mmol, 70 %) as a pale yellow oil. 
Spectral data for 10 as a mixture of rotamers: 1H NMR (600 MHz, CDCl3) δ 7.38 (t, J = 7.8 
Hz, 0.5H), 7.35 (t, J = 7.2 Hz, 0.5H), 7.30 (d, J = 9.0 Hz, 0.5H), 7.29 (d, J = 8.4 Hz, 0.5H), 
7.05 (d, J = 8.4 Hz, 1H), 5.90-5.80 (m, 1H), 5.19 (d, J = 16.8 Hz, 1H), 5.18 (d, J = 10.8 Hz, 
1H), 4.70 (s, 0.5H), 4.69 (s, 0.5H), 3.96-4.14 (m, 2H), 2.77 (d, J = 13.2 Hz, 0.5H), 2.62 (d, J 
= 9.6 Hz, 0.5H), 2.52-2.44 (m, 1H), 2.20-2.14 (m, 1H), 2.04-1.96 (m, 1H), 1.48 (s, 9H); 13C 
NMR (150 MHz, CDCl3) δ 155.3, 155.2, 153.8, 153.3, 152.2, 152.2, 134.3, 134.0, 128.4, 
128.3, 118.7, 118.6, 116.6, 116.5, 116.1, 116.0, 105.5, 105.3, 82.4, 81.1, 79.6, 79.6, 62.9, 
62.7, 60.3, 53.2, 53.1, 37.4, 36.4, 36.1, 35.5, 28.4, 21.7, 20.5; IR (ATR) 2976, 1682, 1534, 
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1387, 1269 cm-1; [α]25D = 0.12 ± 0.01 (c 1.0, MeOH); HRMS (ESI) calcd for C19H26BrN2O5 
(M+H+) 441.1026, found 441.1023. 
 
Tricyclic Compound 11  
A solution of 10 (200 mg, 0.45 mmol), Pd(OAc)2 (7.4 mg, 0.03 mmol), and tri(o-
tolyl)phosphine (39 mg, 0.13 mmol) in triethylamine (7 mL) in a Teflon screw-capped 
ACEGlass pressure tube was stirred at 120 °C for 31 h. The solvent was removed, and the 
resulting residue was purified by chromatography (hexanes/EtOAc, 9:1) to give (47 mg, 0.13 
mmol, 29 %) as a white solid.46 
Spectral data for 11 as a 1:1 mixture of rotamers: mp 125-127 °C; 1H NMR (600 MHz, 
CDCl3) δ 7.63 (dd, J = 7.2, 2.4 Hz, 1H), 7.28-7.24 (m, 2H), 6.08 (br s, 1H), 5.83 (br s, 
0.5H), 5.73 (br s, 0.5H), 4.90 (br s, 1H), 3.80 (ddt, J = 16.8, 10.2, 7.2 Hz, 3H), 3.29 (dd, J = 
12.6, 7.2 Hz, 1H), 2.57 (br s, 1H), 1.93 (dt, J = 12.6, 10.8 Hz, 1H), 1.48 (s, 9H), 1.45 (s, 3H); 
13C NMR (150 MHz, CDCl3) δ 158.8, 153.9, 149.9, 136.2, 134.3, 133.2, 128.4, 128.2, 127.7, 
127.3, 126.8, 125.9, 120.6, 120.5, 87.3, 86.8, 80.0, 61.8, 56.4, 52.2, 51.6, 40.3, 37.4, 28.4, 
26.4, 21.8, 20.1; IR (ATR) 1691,1528, 1154, 1031, 712 cm−1; [α]25D = 159.0 ± 0.6 (c 1.0, 
MeOH); HRMS (ESI) calcd for C19H25N2O5 (M+H
+) 361.1758, found 361.1758. 
 
2(R)-(2-Bromo-2-propen-1-yl)-3(R)-[(tert-butyldimethylsilyl)-oxy]-5(R)-methyl-
pyrrolidine (14) and 5(R)-[(tert-Butyldimethylsilyl)oxy]-(4a)-hexahydro-3-methylene-
7(R)-methyl-1H-pyrrolo[1,2-c][1,3]oxazin-1-one (15) 
A solution of 1 (123 mg, 0.36 mmol) and 2-bromo-2-propen-1-yl trimethylsilane (13) (250 
μL, 1.43 mmol) in CH2Cl2 (4 μL) was cooled to -78 °C and stirred for 15 min. A solution of 
TiCl4 (74 μL, 0.67 mmol) in CH2Cl2 (1.5 mL) was added slowly. The cold bath was 
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removed after 5 min, and the mixture was stirred at ambient temperature for an additional 1 
h. Na2CO3·10H2O (1.2 g) was added slowly. After stirring for 30 min, the mixture was dried 
(MgSO4) and filtered, and the solvent was removed. Purification by chromatography 
(hexanes/EtOAc, 1:1) gave, in order of elution, 15 (32 mg, 0.11 mmol, 30 %, dr = 1.8:1) as a 
pale brown oil and 14 (67 mg, 0.20 mmol, 56 %, dr approximately 9:1)47 as a brown oil. 
Spectral data for the major isomer of 14: 1H NMR (400 MHz, CDCl3) δ 5.74 (d, J = 1.2 Hz, 
1H), 5.49 (d, J = 1.6 Hz, 1H), 4.58 (br s, 1H), 4.30 (br dt, 1H), 3.66 (dpent, J = 8.6, 6.7 Hz, 
1H), 3.58 (dt, J = 6.7, 3.9 Hz, 1H), 2.69 (d, J = 6.7 Hz, 2H), 1.96 (ddd, J = 13.3, 7.0, 2.0 Hz, 
1H), 1.60 (ddd, J = 13.3, 9.0, 4.3 Hz, 1H), 1.26 (d, J = 6.2 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 
3H), 0.06 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 131.3, 118.8, 73.4, 61.0, 51.7, 43.4, 40.9, 
25.8, 21.4, 18.0, -4.4, -4.9; IR (ATR) 2956, 1701, 1125, 1051, 833, 773 cm-1; [α]25D = -12 ± 
2 (c 0.1, CHCl3); HRMS (ESI) calcd for C14H29BrNOSi (M+H
+) 334.1202, found 334.1197. 
Spectral data from a 1:1 mixture of diastereomeric 15: 1H (600 MHz, CDCl3) NMR δ 4.65-
4.63 (br m, 2H), 4.24 (t, J = 1.8 Hz, 1H), 4.22 (t, J = 1.8 Hz, 1H), 4.17 (t, J = 3.0 Hz, 1H), 
4.10 (dp, J = 6.8, 4.0 Hz, 1H), 4.06 (br dp, J = 5.2, 4.4 Hz, 1H), 3.96 (ddd, J = 14.4, 7.8, 6.6 
Hz, 1H), 3.59 (ddd, J = 12.0, 4.2, 3.6 Hz, 1H), 3.27 (ddd, J = 11.4, 7.8, 3.0 Hz, 1H), 2.81 
(dd, J = 13.8, 3.0 Hz, 1H), 2.51 (ddt, J = 13.5, 11.8, 1.8 Hz, 1H), 2.37 (dd, J = 13.2, 4.2 Hz, 
1H), 2.16 (ddt, J = 13.8, 12.0, 1.8 Hz, 1H), 2.07 (dd, J = 13.2, 6.6 Hz, 1H), 1.95 (ddd, J = 
19.2, 10.2, 8.4 Hz, 1H), 1.84 (dd, J = 12.6, 6.0 Hz, 1H), 1.57 (ddd, J = 13.8, 10.2, 3.6 Hz, 
1H), 1.35 (d, J = 6.0 Hz, 3H), 1.28 (d, J = 6.6 Hz, 3H), 0.88 (s, 9H), 0.85 (s, 9H), 0.08 (s, 
3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.04 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 152.7, 152.3, 
150.4, 149.0, 92.9, 92.8, 74.4, 71.3, 60.6, 60.0, 53.2, 51.9, 41.8, 39.6, 31.7, 26.5, 25.6, 25.5, 
20.8, 19.9, 17.9, 17.8, -4.6, -4.7, -4.9, -5.1; IR (ATR) 2930, 1721, 1251, 1057, 832 cm-1; 
HRMS (ESI) calcd for C15H28NO3Si (M+H
+) 298.1838, found 298.1829. 
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2(R)-(2-Bromo-2-propen-1-yl)-3(R)-[(tert-butyldimethylsilyl)-oxy]-1-(t-
butoxycarbonyl)-5(R)-methyl-pyrrolidine (16) and (15) 
A solution of 1 (100 mg, 0.29 mmol) and 2-bromoallyltrimethylsilane (13) (200 μL, 1.16 
mmol) in CH2Cl2 (2 mL) was cooled to -78 °C and stirred for 15 min. BF3·Et2O (82 μL, 0.66 
mmol) was added slowly. The mixture was stirred at -78 °C for 1 h and then slowly warmed 
to -30 °C in 1 h and stirred for additional 1.5 h. Then, the mixture was quenched by pouring 
it into NaHCO3 (sat. aqueous, 10 mL) at -30 °C. The mixture was warmed to ambient 
temperature and extracted with EtOAc (3x10 mL). The combined organic phases were dried 
(MgSO4) and filtered, and the solvents were removed. The resulting residue was purified by 
chromatography (hexanes/EtOAc, 60:1) to afford, in order of elution, 16 (54 mg, 0.12 mmol, 
43 %, dr = 8:1) as a colorless oil and 15 (20 mg, 0.07 mmol, 23 %, dr = 1.1:1) as a brown 
oil. 
Spectral data for major isomer/rotamer of 16: 1H NMR (400 MHz, CDCl3, 65 °C) δ 5.59 (d, 
J = 1.0 Hz, 1H), 5.39 (s, 1H), 4.46 (dt, J = 10.8, 6.8 Hz, 1H), 4.17-4.08 (m, 1H), 3.84 (pent, 
J = 6.6 Hz, 1H), 2.86 (dd, J = 15.1, 6.4 Hz, 1H), 2.67-2.53 (m, 1H), 2.10-2.0 (m, 1H), 1.66 
(dd, J = 11.0, 6.6 Hz, 1H), 1.45 (s, 9H), 1.19 (d, J = 6.3 Hz, 3H), 0.88 (s, 9H), 0.06 (s, 6H). 
Partial spectral data for minor isomer/rotamer of 16: 1H NMR (400 MHz, CDCl3, 65 °C) δ 
5.58 (s, 1H), 5.46 (d, J = 0.9 Hz, 1H), 4.31 (pent, J = 4.7 Hz, 1H), 3.41 (dd, J = 11.2, 4.8 Hz, 
1H), 2.7 (br d, 1H), 1.44 (s, 9H). 
Spectral data for mixture of both isomers of 16: 13C NMR (100 MHz, CDCl3) δ 155.3, 153.9, 
132.0, 131.8, 118.9, 118.4, 118.2, 79.8, 79.3, 78.9, 70.6, 70.0, 66.2, 58.5, 58.3, 52.5, 51.7, 
50.4, 50.1, 40.8, 39.5, 39.4, 38.6, 28.5, 25.8, 25.7, 25.6, 22.1, 21.0, 18.2, 17.9, 17.8, -4.7, -
4.8, -4.8, -4.9, -4.9; IR (ATR) 2957,1694, 1384, 1068, 774 cm-1; HRMS (ESI) calcd for 
C19H37BrNO3Si (M+H




To a suspension of 14 (61 mg, 0.18 mmol) and CH2Cl2 (1.0 mL) was added triethylamine 
(73 μL, 0.52 mmol), followed by dropwise addition of methyl chloroformate (30 μL, 0.39 
mmol). The reaction mixture was stirred at ambient temperature for 20 h then poured into 
brine (20 mL) and extracted with EtOAc (3x20 mL). The organic phases were combined, 
dried (MgSO4), and filtered. The solvents were removed, and the resulting residue was 
purified by chromatography (hexanes/EtOAc, 40:1) to give 17 (29 mg, 0.074 mmol, 41 %, 
dr approximately 9:1) as a colorless oil. 
Spectral data for 17 from the mixture of isomers. Major isomer: 1H NMR (600 MHz, CDCl3, 
65 °C) δ 5.55 (s, 1H), 5.39 (s, 1H), 4.48 (dt, J = 11.4, 7.2 Hz, 1H), 4.19 (q, J = 6.0 Hz, 1H), 
3.91 (pent, J = 6.6 Hz, 1H), 3.63 (s, 3H), 2.87 (dd, J = 15.0, 5.4 Hz, 1H), 2.53 (br s, 1H), 
2.11-2.02 (q, J = 9.6 Hz, 1H), 1.70 (dd, J = 12.6, 6.6 Hz, 1H), 1.22 (d, J = 6.1 Hz, 3H), 0.90 
(s, 9H), 0.08 (s, 6H). 
Partial spectral data for the minor isomer: 1H NMR (600 MHz, CDCl3, 65 °C) δ 4.35 (pent, J 
= 4.8 Hz, 1H), 4.00 (m, 1H), 3.67 (s, 3H). 
From the mixture of isomers/rotamers at ambient temperature: 13C NMR (150 MHz, CDCl3) 
δ 155.3, 132.2, 118.5, 117.8, 70.1, 59.0, 58.2, 52.0, 51.4, 50.3, 41.3, 39.6, 39.4, 38.5, 25.8, 
25.7, 21.9, 21.0, 18.1, -4.9, -4.9; IR (ATR) 2955,1702, 1371, 1079, 774 cm-1; [α]25D = 2.4 ± 
0.1 (c 1.0, CHCl3); HRMS (ESI) calcd for C16H30BrNNaO3Si (M+Na






Alternative synthesis of 17  
A solution of 1 (687 mg, 1.99 mmol) and 2-bromoallyltrimethylsilane (13) (1.37 mL, 7.97 
mmol) in CH2Cl2 (22 mL) was cooled to -78 °C and stirred for 15 min. TiCl4 (410 μL, 3.74 
mmol) in CH2Cl2 (8 mL) was added slowly. The cold bath was removed after 5 min, and the 
mixture was stirred at ambient temperature for an additional 1 h. Na2CO3·10H2O (6.68 g) 
was added slowly. After stirring for 30 min, the mixture was dried (MgSO4) and filtered, and 
the solvent was removed to give a light yellow residue (802 mg). The residue was dissolved 
in CH2Cl2 (6 mL), and triethylamine (960 μL, 6.92 mmol) was added followed by dropwise 
addition of methyl chloroformate (400 μL, 5.16 mmol). The reaction mixture was stirred at 
ambient temperature for 18 h. Brine (50 mL) was added, and the mixture was extracted with 
EtOAc (3x50 mL). The combined organic phases were dried (MgSO4) and filtered, and the 
solvents were removed. The resulting residue was purified by chromatography 




methylpyrrolidine (18)  
To a solution of 17 (191 mg, 0.49 mmol) in THF (4 mL) was added tetrabutylammonium 
fluoride (1.0 M in THF, 0.93 mL). The reaction mixture was stirred at ambient temperature 
for 2 h. The resulting mixture was poured into H2O (20 mL) and extracted with EtOAc 
(3x20 mL). The combined organic phases were dried (MgSO4) and filtered, and the solvents 
were removed. Purification by chromatography (hexanes/EtOAc, 3:1) gave 18 (112 mg, 0.40 
mmol, 82 %)48 as a white solid. 
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Spectral data for 18 as a mixture of rotamers: mp 65-66 °C; 1H NMR (600 MHz, CDCl3) δ 
5.69 (s, 0.4H), 5.62 (s, 0.6H), 5.46 (s, 1H), 4.57 (m, 1H), 4.18 (td, J = 6.0, 4.2 Hz, 1H), 3.94 
(s, 1H), 3.66 (s, 3H), 2.98 (s, 0.4H), 2.87 (dd, J = 14.4, 7.2 Hz, 1H), 2.57 (s, 0.6H), 2.00-2.35 
(br m, 2H), 1.84 (dd, J = 11.4, 5.4 Hz, 1H), 1.22 (s, 3H); 13C NMR (150 MHz, CDCl3) major 
rotamer δ 155.2, 131.6, 118.0, 69.1, 57.8, 51.4, 50.3, 40.9, 37.4, 20.4; Partial 13C NMR (150 
MHz, CDCl3) spectral data for minor rotamer δ 131.1, 118.6, 58.8, 51.9, 50.7, 39.0, 38.7, 
21.3; IR (ATR) 3359, 2965, 1668, 1376, 1068, 734 cm-1; [α]25D = -11.6 ± 0.1 (c 1.0, CHCl3); 
HRMS (ESI) calcd for C10H16BrNNaO3 (M+Na
+) 300.0211, found 300.0200. 
 
3(S)-(2-Bromo-3-nitrophenoxy)-2(R)-(2-bromo-propen-1-yl)-1-(methoxycarbonyl)-
5(R)-methylpyrrolidine (19)  
To a solution of 18 (607 mg, 2.18 mmol) in THF (32 mL) were added triphenylphosphine 
(1.95 g, 7.45 mmol) and 9 (713 mg, 3.27 mmol). The solution was cooled to 0 °C, and 
diisopropylazodicarboxylate (1.74 mL, 8.84 mmol) was added dropwise. The mixture was 
stirred at ambient temperature for 19 h; brine (50 mL) was added, and the mixture was 
extracted with EtOAc (3x50 mL). The combined organic phases were dried (MgSO4) and 
filtered, and the solvent was removed at reduced pressure. Purification by chromatography 
(CH2Cl2/hexanes, 1:1, then CH2Cl2) gave 19 (693 mg, 1.45 mmol, 66 %) as a pale yellow 
oil. 
Spectral data for 19 as a mixture of rotamers: 1H NMR (600 MHz, CDCl3) δ 7.38 (t, J = 8.2 
Hz, 0.5H), 7.37 (t, J = 8.1 Hz, 0.5H), 7.32 (d, J = 7.0 Hz, 0.5H), 7.31 (d, J = 7.9 Hz, 0.5H), 
7.11 (d, J = 8.2 Hz, 0.5H), 7.10 (d, J = 8.2 Hz, 0.5H), 5.73 (s, 0.5H), 5.71 (s, 0.5H), 5.61 (s, 
1H), 4.88 (d, J = 4.7 Hz, 0.5H), 4.83 (d, J = 4.6 Hz, 0.5H), 4.40 (dd, J = 10.0, 2.3 Hz, 0.5H), 
4.31 (dd, J = 9.9, 2.8 Hz, 0.5H), 4.16 (pd, J = 6.3, 2.3 Hz, 0.5H), 4.08 (d, J = 6.4 Hz, 0.5H), 
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3.72 (s, 1.5H), 3.71 (s, 1.5H), 3.19 (dd, J = 14.5, 2.8 Hz, 0.5H), 2.94 (dd, J = 14.3, 3.0 Hz, 
0.5H), 2.56-2.39 (m, 2H), 2.08 (d, J = 14.2 Hz, 0.5H), 2.06 (d, J = 14.5 Hz, 0.5H), 1.54 (d, J 
= 6.4 Hz, 1.5H), 1.48 (d, J = 6.5 Hz, 1.5H); 13C NMR (150 MHz, CDCl3) δ 154.9, 154.8, 
154.8, 154.3, 152.0, 152.0, 129.2, 129.2, 128.5, 128.5, 120.4, 120.4, 116.9, 116.8, 116.3, 
116.3, 105.4, 105.3, 81.4, 80.4, 62.6, 61.5, 53.5, 53.0, 52.2, 52.1, 44.1, 42.4, 36.2, 35.3, 21.5, 
20.4; IR (ATR) 2954, 1686, 1533, 1357, 1268, 732 cm-1; [α]25D = -1.4 ± 0.1 (c 1.0, CHCl3); 
HRMS (ESI) calcd for C16H18Br2N2NaO5 (M+Na
+) 498.9480, found 498.9462. 
 
Tricyclic Compound 20  
A solution of 19 (100 mg, 0.21 mmol), Pd(dba)2 (30 mg, 0.05 mmol), triphenylphosphine 
(55 mg, 0.21 mmol), and hexamethylditin (105 mg, 0.32 mmol) in toluene (2 mL) was 
stirred at 140 °C for 3 h. The mixture was cooled to ambient temperature, diluted with 
EtOAc (4 mL), and washed with NH4OH (10 % aqueous, 4x2 mL). The organic phase was 
dried (MgSO4) and filtered. The solvent was removed, and the resulting residue was purified 
by chromatography (hexanes/EtOAc, 10:1) to give 20 (29 mg, 0.09 mmol, 44 %)49 as a 
brown solid. 
Spectral data for 20 as a mixture of rotamers:50 mp 139-142 °C; 1H NMR (600 MHz, CDCl3, 
65 °C) δ 7.35 (br s, 1H), 7.22 (t, J = 7.8 Hz, 1H), 7.08 (br s, 1H), 5.26 (br s, 1H), 4.94 (s, 
1H), 3.91 (br m, 2H), 3.70 (s, 3H), 2.53 (dt, J = 12.6, 7.2 Hz, 1H), 2.31 (br s, 1H), 1.74 (dd, 
J = 15.6, 9.6 Hz, 1H), 1.36 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 158.0, 155.2, 155.1, 
154.7, 151.7, 139.3, 138.7, 129.3, 128.8, 128.3, 124.0, 121.9, 120.7, 119.7, 118.9, 116.1, 
85.3, 78.6, 62.1, 57.5, 52.7, 52.0, 51.3, 43.5, 42.4, 39.5, 38.3, 37.7, 21.6, 20.1; IR (ATR) 
2955, 1695, 1527, 1251, 1071, 733 cm-1; [α]25D = -240.9 ± 0.3 (c 1.0, CHCl3); HRMS (ESI) 
calcd for C16H18N2NaO5 (M+Na




A solution of 20 (119 mg, 0.37 mmol), Pd(dba)2 (12.9 mg, 0.02 mmol), 1,3- 
bis(diphenylphosphino)propane (9.23 mg, 0.02 mmol), and 1,10-phenanthroline (8.12 mg, 
0.05 mmol) in anhydrous DMF (1.2 mL) in a Teflon screw-capped ACE-Glass pressure tube 
was saturated with carbon monoxide (4 cycles to 6 atm of CO). The reaction mixture was 
stirred under CO (6 atm) at 120 °C for 37 h. The mixture was cooled to ambient temperature, 
diluted with EtOAc (10 mL), and washed with brine (2x10 mL). The organic phase was 
dried (MgSO4) and filtered. The solvent was removed, and the resulting residue was purified 
by chromatography (hexanes/EtOAc, 4:1) to afford 21 (76 mg, 0.27 mmol, 71 %) as a white 
solid. 
Spectral data for 21 from a mixture of rotamers: mp 190-193 °C; 1H NMR (600 MHz, 
CDCl3) δ 8.27 (br s, 1H), 7.07 (t, J = 7.8 Hz, 1H), 6.99 (dd, J = 7.8, 0.6 Hz, 1H), 6.97 (br s, 
1H), 6.65 (d, J = 7.8 Hz, 1H), 4.44 (apparent dt, J = 7.8, 1.8 Hz, 1H), 4.35 (br s, 0.5H), 4.02 
(br pent, J = 4.6 Hz, 1H), 3.95 (dpent, J = 9.6, 6.6 Hz, 1H), partially overlapping 3.9 (br s, 
0.5H), 3.75 (s, 3H), 2.64 (br s, 1H), 2.54 (br s, 1H), 2.01 (dt, J = 12.6, 9.6 Hz, 1H), 1.53 (br 
s, 1.5H), 1.43 (br s, 1.5H); 13C NMR (150 MHz, CDCl3) δ 155.2, 151.5, 138.6, 122.6, 120.8, 
116.8, 109.7, 105.6, 104.3, 84.4, 63.4, 52.3, 51.9, 39.7, 31.4, 30.1, 21.5, 20.0; IR (ATR) 
3323, 2925, 1676, 1074, 733 cm-1; [α]25D = -286.5 ± 0.4 (c 1.0, CHCl3); HRMS (ESI) calcd 
for C16H19N2O3 (M+H







To a solution of 21 (116 mg, 0.41 mmol) in anhydrous toluene (40 mL) was added sodium 
bis(2-methoxyethoxy)aluminumhydride (in toluene ∼3.5 M, 2.56 mL, 8.96 mmol) dropwise. 
The mixture was stirred at 110 °C for 5 h and then allowed to cool to ambient temperature. 
Brine (80 mL) was added, and the mixture was extracted with EtOAc (3x80 mL). The 
organic phases were combined, dried (MgSO4), and filtered. The solvent was removed, and 
the resulting residue was purified by chromatography (EtOAc) to give ht-13-B (88 mg, 0.36 
mmol, 88 %) as a white solid. 
Spectral data for synthetic ht-13-B: mp 180-182 °C; 1H NMR (600 MHz, CDCl3) δ 8.35 (br 
s, 1H), 7.07 (t, J = 7.8 Hz, 1H), 6.98 (s, 1H), 6.97 (d, J = 7.8 Hz, 1H), 6.64 (d, J = 7.8 Hz 
1H), 4.45 (ddd, J = 10.2, 6.0, 4.2 Hz, 1H), 3.45 (dpent, J = 6.6, 2.4 Hz, 1H), 3.37 (dd, J = 
15.0, 4.2 Hz, 1H), 3.17 (ddd, J = 12.0, 6.0, 4.2 Hz, 1H), 2.73 (ddd, J = 14.4, 10.2, 7.8 Hz, 
1H), 2.65 (ddd, J = 14.4, 12.0, 1.8 Hz, 1H), 2.45 (s, 3H), 1.87 (ddd, J = 13.8, 3.6, 2.4 Hz, 
1H), 1.19 (d, J = 6.6 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 152.0, 138.8, 122.7, 120.3, 
117.0, 110.7, 106.0, 104.0, 86.1, 67.3, 57.9, 38.6, 35.0, 29.0, 14.2; IR (ATR) 3400, 3154, 
2925, 1244, 1067, 733 cm-1; [α]25D = -202.1 ± 0.1 (c 1.0, CHCl3); HRMS (ESI) calcd for 
C15H19N2O (M+H
+) 243.1497, found 243.1492. 
 
3-(tert-Butyl-dimethyl-silanyloxy)-2-methoxy-pyrrolidine-1-carboxylic acid tert-butyl 
ester (28)  
Lithium triethylborohydride in THF (1.0 M in THF, 18.8 mL) was added to a solution of 27 
(9.89 g, 31.33 mmol) in THF (125 mL) at -78 ºC. After 40 min, the reaction was quenched 
with H2O (100 mL) and the mixture was allowed to warm to room temperature. The mixture 
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was extracted with EtOAc (3x100 mL), dried (MgSO4) and the solvents were removed on a 
rotary evaporator at water aspirator pressure. The crude product was dissolved in THF (370 
mL), methyl iodide (5.02 mL, 80.59 mmol) and NaH (60 %, 2.15 g, 53.75 mmol) were 
added, and the mixture was stirred at room temperature for 16 h. The reaction was quenched 
with H2O (500 mL) and extracted with EtOAc (3x200 mL), dried (MgSO4) and the solvents 
were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 10:1) gave 28 (3.46 g, 10.43 mmol, 33 %) as a yellow oil. 
Spectral data for 28 as mixture of rotamers: 1H NMR(400 MHz, CDCl3)  4.88 (s, 0.5H), 
4.76 (s, 0.5H), 4.10 (s, 0.5H), 4.09 (s, 0.5H), 3.54-3.64 (m, 0.5H), 3.43-3.54 (m, 0.5H), 3.38 
(s, 1.5H), 3.37-3.38 (m, 0.5H), 3.34-3.35 (m, 0.5H), 3.33 (s, 1.5H), 1.98-2.13 (m, 1H), 1.70-
1.80 (m, 1H), 1.48 (s, 9H), 0.91 (s, 2H), 0.86 (s, 7H), 0.09 (s, 1H), 0.07 (s, 2.5H), 0.06 (s, 
2.5H). 13C NMR(150 MHz, CDCl3)  155.8, 155.2, 94.2, 94.1, 79.8, 79.6, 75.0, 74.2, 55.9, 
55.4, 44.5, 43.9, 31.6, 30.8, 28.4, 28.3, 25.6, 25.6, 17.9, 17.9, -4.8, -4.9, -5.0; IR (ATR) 2930, 
2858, 1703, 1386, 1364, 1080, 832, 773 cm-1;[α]25D = +1.0 ± 0.2 (c 1.0, MeOH); HRMS 
(ESI) calcd for C16H33NNaO4Si (M+Na
+) 354.2077, found 354.2080. 
 
2-(2-Bromo-allyl)-3-(tert-butyl-dimethyl-silanyloxy)-pyrrolidine-1-carboxylic acid tert-
butyl ester (29) and 5-(tert-Butyl-dimethyl-silanyloxy)-3-methylene-hexahydro-
pyrrolo[1,2-c][1,3]oxazin-1-one (30) 
A solution of 28 (100 mg, 0.30 mmol) and 2-bromoallyltrimethylsilane (13) (0.21 mL, 1.22 
mmol) in CH2Cl2 (2 mL) was cooled to -78 ºC under N2 and stirred for 15 min. BF3
.OEt2 
(48 %, 86 L, 0.685 mmol) was added slowly. The mixture was stirred under N2 for 1 h 
during which time the temperature raised to -60 oC. The reaction was quenched with 
saturated NaHCO3 (aq. 8 mL) at -60 
oC. Then the mixture was warmed to room temperature 
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and extracted with EtOAc (3x10 mL), dried (MgSO4) and the solvents were removed on a 
rotary evaporator at water aspirator pressure. Purification by chromatography 
(hexanes/EtOAc, 10:1) gave 29 (51 mg, 0.12 mmol, 40 %, dr = 6:1) as a colorless oil and 
(hexanes/EtOAc, 3:1) gave 30 (8.3 mg, 0.029 mmol, 10 %) as a white solid. 
Spectral data for major isomer of 29: 1H NMR(400 MHz, CDCl3, 65 
oC)  5.60 (s, 1H), 5.41 
(s, 1H), 4.34 (dd, J = 14.6, 6.6 Hz, 1H), 4.10 (q, J = 6.2 Hz, 1H), 3.31-3.46 (m, 3H), 2.84 (dd, 
J = 14.9, 5.9 Hz, 1H), 1.94-2.02 (m, 1H), 1.76-1.85 (m, 1H), 1.46 (s, 9H), 0.91 (s, 9H), 0.08 
(s, 6H).  
Spectral data for 29 as mixture of isomers: 13C NMR (100 MHz, CDCl3, 65 
oC)  154.7, 
131.8, 118.9, 118.8, 118.1, 118.0, 79.6, 79.0, 72.0, 58.7, 42.9, 40.3, 31.8, 28.5, 28.5, 25.9, 
25.8, 25.8, 18.1, 18.0, 18.0, 17.9, -4.7, -4.7, -4.9, -4.9; IR (ATR) 2971, 1740, 1696, 1388, 
1365, 1217, 1115, 834, 774 cm-1; HRMS (ESI) calcd for C18H35BrNO3Si (M+H
+) 420.1570, 
found 420.1555. 
Spectral data for 30: mp 69-70 oC; 1H NMR(400 MHz, CDCl3)  4.68 (s, 1H), 4.28-4.31 (m, 
1H), 4.26 (t, J = 1.7 Hz, 1H), 3.60-3.70 (m, 1H), 3.50-3.60 (m, 2H), 2.48-2.58 (m, 1H),   
2.42 (dd, J = 13.8, 4.1 Hz, 1H), 1.89-1.95 (m, 2H), 0.88 (s, 9H), 0.09 (s, 2H), 0.08 (s, 3H); 
13C NMR (100 MHz, CDCl3)  152.9, 150.5, 93.2, 72.1, 59.8, 44.6, 32.6, 26.8, 25.6, 18.0,    
-4.7, -5.0; IR (ATR) 3457, 3017, 2971, 2929, 2857, 1737, 1664, 1417, 1354, 1217, 1099, 
835, 777 cm-1; HRMS (ESI) calcd for C14H26NO3Si (M+H
+) 284.1682, found 284.1668. 
 
2-(2-Bromo-allyl)-3-(tert-butyl-dimethyl-silanyloxy)-pyrrolidine (31) and and 5-(tert-
Butyl-dimethyl-silanyloxy)-3-methylene-hexahydro-pyrrolo[1,2-c][1,3]oxazin-1-one (30) 
A solution of 28 (306 mg, 0.92 mmol) and 2-bromoallyltrimethylsilane (13) (0.64 mL, 3.69 
mmol) in CH2Cl2 (10 mL) was cooled to -78 ºC under N2 and stirred for 15 min. TiCl4 (0.2 
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mL, 1.85 mmol) in CH2Cl2 (4 mL) was added slowly. The cold bath was removed after 15 
min and the mixture was stirred at ambient temperature for an additional 1 h. 
Na2CO3·10H2O (3.1 g) was added slowly. After stirring for 15 min, the mixture was dried 
(MgSO4), filtered, and the solvent was removed on a rotary evaporator at water aspirator 
pressure. Purification by chromatography (hexanes/EtOAc, 3:1) gave 30 (24 mg, 0.085 
mmol, 9 %, dr = 12:1) as a white solid and (MeOH/EtOAc, 1:10) gave 31 (148 mg, 0.46 
mmol, 50 %) as a yellow solid. 
Spectral data for 31: 1H NMR(400 MHz, CDCl3)  5.82 (s, 1H), 5.62 (br s, 1H), 5.52 (d, J = 
1.6 Hz, 1H), 4.26-4.32 (m, 1H), 3.37-3.47 (m, 1H), 3.29 (dd, J = 19.2, 8.4 Hz, 1H), 3.07-
3.17 (m, 1H), 2.82 (dd, J = 15.1, 7.7 Hz, 1H), 2.74 (dd, J = 15.0, 5.7 Hz, 1H), 1.98-2.09 (m, 
1H), 1.81-1.90 (m, 1H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (100 MHz, CDCl3) 
 130.6, 119.2, 72.6, 61.8, 43.3, 40.4, 35.0, 25.8, 18.0, -4.4, -4.9; IR (ATR) 2928, 2857, 




3(R)-tert-Butyldimethylsilyloxy-1-(methoxycarbonyl)pyrrolidin-2-one (33)  
Lithium bis(trimethylsilyl)amide (1.0 M in THF, 251 L, 0.25 mmol) was added to a 
solution of 3(R)-hydroxypyrrolidin-2-one (22) (54 mg, 0.25 mmol) in THF (1.0 mL) at -78 
oC. The mixture was stirred at -78 oC under an atmosphere of N2 for 30 min. Methyl 
chloroformate (21 L, 0.28 mmol) was added slowly. The mixture was allowed to warm to 
ambient temperature over 1.5 h, then quenched by H2O (10 mL) and extracted with EtOAc 
(3x10 mL). The combined organic phases were dried (MgSO4), filtered, and the solvents 
were removed. Purification by chromatography on silica gel (hexanes/EtOAc, 8:1) gave 33 
(54 mg, 0.20 mmol, 79 %) as a white solid.  
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Spectral data for 33: mp 66-66.5 oC; 1H NMR (600 MHz, CDCl3) δ 4.33 (dd, J = 9.4, 7.9 
Hz, 1H), 3.85 (s, 3H), 3.84 (ddd, J = 11.1, 8.7, 2.3 Hz, 1H), 3.52 (ddd, J = 10.9, 9.7, 6.8 
Hz, 1H), 2.28-2.34 (m, 1H), 1.95 (dq, J = 12.6, 9.4 Hz, 1H), 0.89 (s, 9H), 0.15 (s, 3H), 
0.11 (s, 3H); 13C NMR (100 MHz, CDCl3)  171.8, 151.4, 70.7, 52.6, 41.1, 27.6, 24.9, 
17.4, -5.3, -6.0; IR (ATR) 2956, 2929, 2857, 1790, 1699, 1442, 1388, 1358, 1323, 1150, 
1051, 1003, 905, 838, 778, 697 cm-1; HRMS (ESI) calcd for C12H24NO4Si (M+H
+) 
274.1475, found 274.1470; [α]25D = 51.9 ± 0.2 (c 1.0, CHCl3). 
 
3(R)-tert-Butyldimethylsilyloxy-2(R/S)-hydroxy-1-(methoxycarbonyl)pyrrolidine (34) 
Lithium triethylborohydride (1.0 M in THF, 5.64 mL, 5.64 mmol) was added to a solution 
of 33 (1.29 g, 4.70 mmol) in THF (20 mL) at -78 oC. The mixture was stirred under N2 for 
30 min at -78 oC then quenched with H2O (40 mL). The mixture was warmed to ambient 
temperature and extracted with EtOAc (3x30 mL). The combined organic phases were 
dried (MgSO4), filtered, and the solvents were removed. Purification by chromatography 
on silica gel (hexanes/EtOAc, 5:1) gave 34 (1.06 g, 3.85 mmol, 82 %, dr = 7:1) as a yellow 
oil. 
Spectral data for the major isomer/rotamer of 34:  1H NMR (600 MHz, CDCl3, 65 
oC) δ 
5.19 (s, 1H), 4.18 (s, 1H), 3.75 (s, 3H), 3.50-3.58 (m, 2H), 2.11-2.19 (m, 1H), 1.75-1.81 
(m, 1H), 0.90 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H).  
 Spectral data from the mixture of both isomers of 34: 13C NMR (150 MHz, CDCl3)  
156.0, 155.2, 87.0, 86.4, 76.6, 75.7, 52.1, 44.0, 43.6, 31.2, 30.3, 25.4, 17.6, -5.2; IR 
(ATR) 3427, 2955, 2931, 2858, 1689, 1453, 1380, 1253, 1103, 1056, 831, 774 cm-1; 
HRMS (ESI) calcd for C12H25NNaO4Si (M+Na




pyrrolidine (32)   
A solution of 34 (996 mg, 3.62 mmol) and 2-bromo-2-propen-1-yl trimethylsilane (13) 
(2.50 mL, 14.5 mmol) in CH2Cl2 (60 mL) was cooled to -78 °C and stirred for 15 min. 
TiCl4 (800 L, 7.30 mmol) was added slowly under a N2 atmosphere. The cold bath was 
removed after 15 min, and the mixture was stirred at ambient temperature for an additional 
1.5 h. Na2CO3·10H2O (12.8 g) was added slowly. After stirring for 30 min, the mixture 
was dried (MgSO4) and filtered. The solvents were removed and the crude product was 
purified by chromatography on silica gel (hexanes/EtOAc, 10:1) to give 32 (988 mg, 2.61 
mmol, 72 %, dr = 6:1) as a colorless oil. 
Spectral data for the major isomer/rotamer of 32 from the mixture:  1H NMR (600 MHz, 
CDCl3, 65 
oC) δ 5.49 (s, 1H), 5.32 (s, 1H), 4.28 (dt, J = 7.9, 6.4 Hz, 1H), 4.05 (q, J = 6.2 
Hz, 1H), 3.56 (s, 3H), 3.28-3.40 (m, 2H), 2.74 (dd, J = 14.9, 5.6 Hz, 1H), 2.55 (br s, 1H), 
1.86-1.96 (m, 1H), 1.68-1.79 (m, 1H), 0.82 (s, 9H), 0.01 (s, 3H), 0.00 (s, 3H); 13C NMR 
(150 MHz, CDCl3, 65 
oC)  155.5, 131.5, 117.6, 71.7, 58.8, 51.6, 42.9, 40.0, 31.6, 25.6, 
17.8, -5.0, -5.2. 
Spectral data for the mixture of both isomers of 32: IR (ATR) 2955, 2930, 2894, 2857, 
1702, 1448, 1383, 1119, 833, 772 cm-1; HRMS (ESI) calcd for C15H28BrNNaO3Si 
(M+Na+) 400.0920, found 400.0919.  
 
Alternative synthesis of 32 
A solution of 28 (195 mg, 0.59 mmol) and 2-bromoallyltrimethylsilane (13) (455 mg, 2.36 
mmol) in CH2Cl2 (6.5 mL) was cooled to -78 °C and stirred for 15 min. TiCl4 (130 μL, 1.18 
mmol) was added slowly. The cold bath was removed after 5 min, and the mixture was 
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stirred at ambient temperature for an additional 1 h. Na2CO3·10H2O (2 g) was added slowly. 
After stirring for 30 min, the mixture was dried (MgSO4) and filtered, and the solvent was 
removed to give a light yellow residue (210 mg). The residue was dissolved in CH2Cl2 (2 
mL), and triethylamine (267 μL, 1.91 mmol) was added followed by dropwise addition of 
methyl chloroformate (110 μL, 1.38 mmol). The reaction mixture was stirred at ambient 
temperature for 4 h. Brine (10 mL) was added, and the mixture was extracted with EtOAc 
(3x10 mL). The combined organic phases were dried (MgSO4) and filtered, and the solvents 
were removed. The resulting residue was purified by chromatography (hexanes/EtOAc, 
20:1) to give 32 (98 mg, 0.26 mmol, 44 %) as a colorless oil. 
 
2(R)-(2-Bromo-2-propen-1-yl)-3(R)-hydroxy-1-(methoxycarbonyl)pyrrolidine (35) and 
2(S)-(2-bromo-2-propen-1-yl)-3(R)-hydroxy-1-(methoxycarbonyl)pyrrolidine (36)  
To a solution of 32 (928 mg, 2.45 mmol) in THF (22 mL) was added tetrabutylammonium 
fluoride (1.0 M in THF, 4.63 mL, 4.63 mmol). The reaction mixture was stirred at ambient 
temperature for 1 h. The resulting mixture was poured into H2O (50 mL) and extracted 
with EtOAc (3x30 mL). The combined organic phases were dried (MgSO4), filtered, and 
the solvents were removed. Purification by chromatography on silica gel (hexanes/EtOAc, 
4:1 followed by 2:1) gave, in order of elution, 35 (438 mg, 1.66 mmol, 68 %) and 36 (103 
mg, 0.39 mmol, 16 %) both as colorless oils. 
Spectral data for 35: 1H NMR (600 MHz, CDCl3, 65 
oC) δ 5.69 (s, 1H), 5.48 (d, J = 1.3 
Hz, 1H), 4.43-4.50 (m, 1H), 4.07 (dt, J = 8.3, 5.4 Hz, 1H), 3.67 (s, 3H), 3.55 (ddd, J = 
10.9, 8.2, 5.1 Hz, 1H), 3.44 (dt, J = 10.9, 7.5 Hz, 1H), 3.01 (br s, 1H), 2.82 (dd, J = 14.5, 
8.3 Hz, 1H), 2.17 (br s, 1H), 1.95-2.05 (m, 1H), 1.88 (ddt, J = 12.7, 7.3, 5.2 Hz, 1H); 13C 
NMR (150 MHz, CDCl3, 65 
oC)  155.8, 131.0, 118.3, 70.8, 59.5, 51.9, 43.7, 39.6, 31.7; 
78  
IR (ATR) 3415, 2954, 2897, 1671, 1451, 1385, 1196, 1108, 1062, 887, 771 cm-1; HRMS 
(ESI) calcd for C9H15BrNO3 (M+H
+) 264.0235, found 264.0231; [α]25D = -28.4 ± 0.1 (c 
1.0, CHCl3). 
Spectral data for 36: 1H NMR (600 MHz, CDCl3, 60 
oC) δ 5.63 (s, 1H), 5.51-5.52 (m, 1H), 
4.32 (d, J = 2.7 Hz, 1H), 4.03 (dd, J = 9.4, 4.2 Hz, 1H), 3.71 (s, 3H), 3.55-3.65 (m, 1H), 
3.44-3.50 (m, 1H), 2.91 (br s, 1H), 2.34 (ddd, J = 14.8, 9.4, 0.6 Hz, 1H), 2.03-2.10 (m, 
1H), 1.96 (br s, 1H), 1.90-1.94 (m, 1H); 13C NMR (150 MHz, CDCl3)  155.8, 155.7, 
129.7, 129.6, 119.2, 119.1, 74.1, 73.2, 65.4, 64.3, 52.4, 44.4, 44.4, 44.2, 43.4, 31.7, 31.0; 
IR (ATR) 3422, 2955, 1673, 1451, 1384, 1197, 1119, 1093, 985, 892, 772 cm-1; HRMS 
(ESI) calcd for C9H15BrNO3 (M+H




pyrrolidine (37)  
To a solution of 35 (422 mg, 1.60 mmol) in THF (25 mL) was added triphenylphosphine 
(1.46 g, 5.58 mmol) and 2-bromo-3-nitrophenol (9) (525 mg, 2.41 mmol). The solution 
was cooled to 0 °C, and diisopropylazodicarboxylate (1.26 mL, 6.40 mmol) was added 
dropwise. The mixture was stirred at ambient temperature for 17 h, brine (50 mL) was 
added, and the resulting mixture was extracted with EtOAc (3x50 mL). The combined 
organic phases were dried (MgSO4), filtered, and the solvent was removed. The crude 
product was purified by chromatography on silica gel (CH2Cl2/hexanes, 1:1, then CH2Cl2) 
to give 37 (530 mg, 1.14 mmol, 71 %) as a pale yellow oil. 
Spectral data for 37: 1H NMR (600 MHz, CDCl3, 65 
oC) δ 7.39 (t, J = 8.2 Hz, 1H), 7.34 
(dd, J = 8.0, 1.3 Hz, 1H), 7.17 (dd, J = 8.2, 1.1 Hz, 1H), 5.72 (s, 1H), 5.58 (d, J = 1.6 Hz, 
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1H), 4.93 (s, 1H), 4.26-4.35 (m, 1H), 3.69-3.79 (m, 1H), 3.72 (s, 3H), 3.57-3.64 (m, 1H), 
3.01 (br s, 1H), 2.50 (dd, J = 14.6, 9.7 Hz, 1H), 2.22-2.29 (m, 2H); 13C NMR (150 MHz, 
CDCl3, 65 
oC)  155.2, 154.8, 151.9, 128.9, 128.4, 120.0, 118.2, 117.4, 106.4, 81.7, 61.9, 
52.2, 44.4, 43.8, 29.1; IR (ATR) 2955, 1693, 1533, 1449, 1386, 1357, 1270, 1196, 1121, 
1010, 903, 773 cm-1; HRMS (ESI) calcd for C15H16Br2N2NaO5 (M+Na
+) 484.9324, found 
484.9322; [α]25D = 30.6 ± 0.1 (c 1.0, CHCl3); 
 
2,3,3a(S),9,10,10a(R)-Hexahydro-1-(methoxycarbonyl)-8-nitro-1H-benzoxepino[3,2-
b]pyrrole (38)  
A solution of 37 (60 mg, 0.13 mmol), Pd(dba)2 (15 mg, 0.026 mmol), triphenylphosphine 
(27 mg, 0.10 mmol), and hexamethylditin (51.5 mg, 0.16 mmol) in toluene (1.5 mL) was 
stirred at 120 °C for 12 h. The mixture was cooled to ambient temperature, the solvent was 
removed and the resulting residue was purified by chromatography on silica gel 
(hexanes/EtOAc, 6:1) to give 38 (16.5 mg, 0.054 mmol, 42 %) as a brown oil. 
Spectral data for 38: 1H NMR (600 MHz, CDCl3) δ 7.42 (d, J = 7.6 Hz, 0.5H), 7.16-7.30 
(m, 2H), 6.96 (d, J = 7.1 Hz, 0.5H), 5.29 (s, 0.5H), 5.10-5.21 (m, 0.5H), 4.93-4.99 (m, 1H), 
3.23-4.06 (m, 8H), 2.48 (t, J = 11.3 Hz, 0.5H), 2.18-2.32 (m, 1.5H), 1.95-2.13 (m, 1H); 13C 
NMR (150 MHz, CDCl3)  158.1, 156.1, 155.3, 152.0, 151.8, 139.1, 138.6, 128.9, 128.8, 
128.3, 123.9, 121.9, 121.5, 120.8, 119.9, 119.7, 118.9, 116.1, 86.8, 80.7, 80.3, 62.5, 57.0, 
56.6, 52.4, 44.2, 44.0, 43.1, 42.4, 39.3, 38.8, 30.8, 30.6, 29.3; IR (ATR) 2956, 2893, 1697, 
1526, 1446, 1386, 1357, 1249, 1191, 1137, 1072, 825 cm-1; HRMS (ESI) calcd for 
C15H17N2O5 (M+H)





[4,3,2-cd]indole (39)   
A solution of 38 (49 mg, 0.16 mmol), Pd(dba)2 (5.6 mg, 0.0097 mmol), 1,3-
bis(diphenylphosphino)propane (4.0 mg, 0.0096 mmol), and 1,10-phenanthroline (3.5 mg, 
0.019 mmol) in anhydrous DMF (800 L) in an ACE-Glass pressure tube with an attached 
pressure head was saturated with carbon monoxide (4 cycles to 6 atm of CO). The reaction 
was stirred under CO (6 atm) at 120 °C for 72 h. The mixture was cooled to ambient 
temperature, diluted with EtOAc (5 mL), and washed with brine (2x5 mL). The organic 
phase was dried (MgSO4) and filtered. The solvent was removed, and the resulting residue 
was purified by chromatography on silica gel (hexanes/EtOAc, 2:1) to afford 39 (29 mg, 
0.11 mmol, 66 %) as a white solid.  
Spectral data for 39: mp 262.5-263 °C; 1H NMR (600 MHz, CDCl3, 65 
oC) δ 8.05 (br s, 
1H), 7.07 (t, J = 7.9 Hz, 1H), 6.99 (d, J = 8.1 Hz, 1H), 6.98 (s, 1H), 6.66 (d, J = 7.7 Hz, 
1H), 4.54 (dt, J = 10.6, 6.8 Hz, 1H), 3.88-4.01 (m, 3H), 3.75 (s, 3H), 3.36 (dt, J = 12.2, 5.6 
Hz, 1H), 2.61 (t, J = 13.2 Hz, 1H), 2.38-2.44 (m, 1H), 2.21-2.30 (m, 1H); 13C NMR (150 
MHz, CDCl3, 65 
oC) δ 155.6, 151.9, 139.1, 122.9, 120.7, 117.2, 110.1, 106.1, 104.4, 86.4, 
62.5, 52.3, 44.2, 31.3, 31.2; IR (ATR) 3280, 1680, 1450, 1390, 1250, 1077, 769, 735 cm-1; 
HRMS (ESI) calcd for C15H17N2O3 (M+H
+) 273.1239, found 273.1238; [α]25D = -288.6 ± 




To a solution of 39 (21 mg, 0.077 mmol) in anhydrous toluene (8.5 mL) was added sodium 
bis(2-methoxyethoxy)aluminumhydride (in toluene ∼3.5 M, 500 L, 1.75 mmol) 
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dropwise. The mixture was stirred at 110 °C for 5 h and then allowed to cool to ambient 
temperature. Brine (20 mL) was added, and the mixture was extracted with EtOAc (3x15 
mL). The combined organic phases were dried (MgSO4), filtered and the solvent was 
removed. The resulting residue was purified by chromatography on silica gel 
(EtOAc/MeOH, 9:1) to give ht-13-A (16.8 mg, 0.074 mmol, 95 %) as a white solid. 
Spectral data for ht-13-A:  mp 228-230 °C; 1H NMR (600 MHz, CDCl3) δ 8.08 (br s, 
1H), 7.07 (d, J = 8.0 Hz, 1H), 7.00 (br s, 1H), 6.99 (t, J = 8.3 Hz, 1H), 6.63 (d, J = 7.7 
Hz, 1H), 4.45 (ddd, J = 9.4, 6.1, 2.9 Hz, 1H), 3.42 (dd, J= 14.6, 3.4 Hz, 1H), 3.11 (t, J = 
8.5 Hz, 1H), 2.62-2.68 (m, 1H), 2.52-2.62 (m, 2H), 2.46-2.52 (m, 1H), 2.43 (s, 3H), 
2.05-2.11 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 151.8, 138.7, 122.8, 120.1, 117.1, 
111.0, 106.1, 104.0, 86.7, 72.9, 55.6, 40.5, 30.8, 29.2; IR (ATR) 3063, 2833, 1620, 
1515, 1457, 1343, 1294, 1240, 1065, 776, 733 cm-1; HRMS (ESI) calcd for C14H17N2O 
(M+H+) 229.1341, found 229.1336; [α]25D = -185.1 ± 0.4 (c 0.36, CHCl3). 
 
Trifluoro-methanesulfonic acid 2-bromo-6-nitro-phenyl ester (43)  
Trifluoromethane-sulfonic anhydride (2.25 mL, 13.4 mmol) was added to a solution of 2-
bromo-6-nitrophenol (42) (2.44 g, 11.17 mmol) and triethylamine (2.34 mL, 16.8 mmol) in 
CH2Cl2 (35 mL) at 0 
oC. The mixture was warmed to room temperature and stirred for 1 h. 
The reaction was quenched with H2O (100 mL) and extracted with EtOAc (3x60 mL), dried 
(MgSO4) and the solvents were removed on a rotary evaporator at water aspirator pressure. 
Purification by chromatography (hexanes/EtOAc, 10:1) gave 43 (3.84 g, 10.97 mmol, 98 %,) 
as a yellow oil.  
Spectral data for 43: 1H NMR (600 MHz, CDCl3)   8.04 (dd, J = 8.2, 1.6 Hz, 1H), 7.98 (dd, 
J = 8.2, 1.7 Hz, 1H), 7.45 (t, J = 8.2 Hz, 1H). 13C NMR (150 MHz, CDCl3)  143.4, 139.2, 
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139.2, 129.5, 125.6, 121.5, 119.4, 118.7, 117.2, 115.1; IR (ATR) 1539, 1431, 1347, 1208, 
1129, 886, 855, 750, 717 cm-1; HRMS (ESI) calcd for C7H3BrF3NNaO5S (M+Na
+) 
371.8765, found 371.8765.  
 
[3-(2-Bromo-6-nitro-phenyl)-but-3-enyl]-carbamic acid methyl ester (45)  
A solution of 43 (930 mg, 2.66 mmol), 44 (822 mg, 2.82 mmol), Pd(PPh3)2Cl2 (37.3 mg, 
0.053 mmol) and lithium chloride (338 mg, 7.97 mmol) in DMF (14 mL) was stirred at 60 
oC for 5 h. The reaction was diluted with H2O (60 mL) and extracted with EtOAc (3x30 
mL), dried (MgSO4) and the solvents were removed on a rotary evaporator at water aspirator 
pressure. Purification by chromatography (hexanes/EtOAc, 20:1) gave 42 (457 mg, 2.10 
mmol, 79 %) as a yellow solid, then (hexanes/EtOAc, 4:1) gave 45 (139 mg, 0.42 mmol, 16 
%) as a brown solid. 
Spectral data for 45: mp 53.5-54 oC; 1H NMR (400 MHz, CDCl3 65 
oC)  7.80 (d, J = 8.0 Hz, 
1H), 7.73 (d, J = 8.1 Hz, 1H), 7.28 (t, J = 8.1 Hz, 1H), 5.34 (s, 1H), 5.04 (s, 1H), 4.88 (br s, 
1H), 3.66 (s, 3H), 3.46 (q, J = 6.3 Hz, 2H), 2.59-2.79 ( m, 2H). 13C NMR (100 MHz, CDCl3) 
 156.9, 150.2, 142.2, 137.5, 136.9, 129.0, 124.4, 122.8, 116.8, 52.0, 38.5, 35.3; IR (ATR) 
3337, 1699, 1525, 1353, 1256, 914, 748, 711 cm-1; HRMS (ESI) calcd for C12H14BrN2O4 
(M+H+) 329.0137, found 329.0137.  
 
Alternative synthesis of 45 
A solution of 50 (16 mg, 0.044 mmol), 51 (9.32 mg, 0.037 mmol), Pd(dba)2 (1.05 mg, 
0.0018 mmol), copper (I) iodide (5.22 mg, 0.027 mmol) and triphenylphosphine (1.92 mg, 
0.0073 mmol) in DMF (0.65 mL) was stirred at room temperature for 16 h. The reaction was 
diluted with H2O (10 mL) and extracted with EtOAc (3x10 mL), dried (MgSO4) and the 
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solvents were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 5:1) gave 45 (2.5 mg, 0.0076 mmol, 21 %) as a brown 
solid. 
 
(2-Bromo-6-nitro-phenyl)-trimethyl-stannane (50)  
Pd(PPh3)2Cl2 (1.6 mg, 0.0023 mmol), hexamethylditin (37.5 mg 0.11 mmol) and 
triphenylphosphine (0.96 mg, 0.0037 mmol) were added to a solution of 1-bromo-2-iodo-3-
nitrobenzene (49) (25 mg, 0.076 mmol) in toluene (0.5 mL) at room temperature. The 
mixture was stirred under N2 at 105 
oC for 16 h. The reaction was quenched with H2O (5 
mL) and extracted with EtOAc (3x5 mL), dried (MgSO4) and the solvents were removed on 
a rotary evaporator at water aspirator pressure. Purification by chromatography 
(hexanes/EtOAc, 20:1) gave 50 (16 mg, 0.044 mmol, 58 %) as a brown oil.  
Spectral data for 50: 1H NMR (600 MHz, CDCl3)  7.92 (d, J = 8.0 Hz, 1H), 7.75 (d, J = 7.9 
Hz, 1H), 7.29 (t, J = 8.0 Hz, 1H), 0.45 (s, 9H).  13C NMR(150 MHz, CDCl3)  157.1, 142.5, 
137.1, 133.2, 130.3, 122.3, -3.8; IR (ATR) 2988, 2909, 1521, 1345, 1078, 773, 737, 714   
cm-1; HRMS (ESI) calcd for C8H9BrNO2Sn (M-CH3
+) 349.8839, found 349.8838.  
 
Trifluoro-methanesulfonic acid 2-iodo-3-nitro-phenyl ester (52) 
Trifluoromethanesulfonic anhydride (0.075 mL, 0.45 mmol) was added to a solution of 2-
iodo-3-nitrophenol (100 mg, 0.38 mmol) and triethylamine (0.058 mL, 0.42 mmol) in 
CH2Cl2 (1 mL) at 0 
oC. The mixture was stirred for 1 h at 0 oC. The reaction was quenched 
with brine (10 mL) and extracted with EtOAc (3x10 mL), dried (MgSO4) and the solvents 
were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 5:1) gave 52 (143 mg, 0.36 mmol, 95 %) as a yellow oil.  
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Spectral data for 52: 1H NMR (600 MHz, CDCl3)   7.76 (dd, J = 8.0, 1.1 Hz, 1H), 7.62 (t, J 
= 8.3 Hz, 1H), 7.55 (dd, J = 8.3, 1.2 Hz, 1H). 13C NMR (150 MHz, CDCl3)  155.6, 151.4, 
130.8, 125.0, 124.2, 121.8, 119.6, 117.5, 115.4, 84.6; IR (ATR) 1535, 1425, 1211, 1131, 938, 
838, 804, 733 cm-1; HRMS (ESI) calcd for C7H3F3INNaO5S (M+Na
+) 419.8626, found 
419.8624.  
 
(2-Benzyloxy-6-nitro-phenyl)-trimethyl-stannane (56)   
Pd(PPh3)2Cl2 (360 mg, 0.51 mmol), hexamethylditin (8.86 g, 27 mmol) and 
triphenylphosphine (223 mg, 0.85 mmol) were added to a solution of 55 (6.39 g, 18 mmol) 
in toluene (115 mL) at room temperature. The mixture was stirred under N2 at 110 
oC for 14 
h. The reaction was quenched with H2O (200 mL) and extracted with EtOAc (3x100 mL), 
dried (MgSO4) and the solvents were removed on a rotary evaporator at water aspirator 
pressure. Purification by chromatography (hexanes/EtOAc, 80:1) gave 56 (5.64 g, 14.39 
mmol, 80 %,) as a yellow solid.  
Spectral data for 56: mp 87-88 oC; 1H NMR (600 MHz, CDCl3)  7.72 (d, J = 8.0 Hz, 1H), 
7.35-7.44 (m, 6H), 7.09 (d, J = 8.1 Hz, 1H), 5.11 (s, 2H), 0.29 (s, 9H); 13C NMR(150 MHz, 
CDCl3)  164.0, 156.0, 135.9, 130.4, 128.6, 128.3, 127.9, 127.8, 116.5, 115.4, 71.0, -5.6; IR 
(ATR) 3069, 3035, 2979, 2917, 1591, 1251, 1021, 738, 698 cm-1; HRMS (ESI) calcd for 
C16H19NNaO3Sn (M+Na
+) 416.0285, found 416.0283.  
 
[3-(2-Benzyloxy-6-nitro-phenyl)-but-3-enyl]-carbamic acid methyl ester (57)  
A solution of 56 (2.0 g, 5.10 mmol), 51 (1.09 g, 4.27 mmol), Pd(dba)2 (123 mg, 0.21 mmol), 
triphenylphosphine (218 mg, 0.83 mmol) and copper (I) iodide (600 mg, 3.15 mmol) in 
DMF (75 mL) was stirred at r.t. for 14 h. The reaction was diluted with H2O (500 mL) and 
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extracted with EtOAc (3x200 mL), dried (MgSO4) and the solvents were removed on a 
rotary evaporator at water aspirator pressure. Purification by chromatography 
(hexanes/EtOAc, 5:1) gave 57 (1.21 g, 3.40 mmol, 79 %) as an orange oil.  
Spectral data for 57: 1H NMR (400 MHz, CDCl3, 65 
oC)  7.23-7.39 ( m, 7H), 7.12 (d, J = 
7.7 Hz, 1H), 5.23 (s, 1H), 5.11 (s, 2H), 4.98 (s, 1H), 4.92 (br s, 1H), 3.59 (s, 3H), 3.33 (q, J 
= 6.3 Hz, 2H), 2.67 (t, J = 6.5 Hz, 2H). 13C NMR (100 MHz, CDCl3)  156.9, 156.3, 150.5, 
139.7, 135.6, 128.7, 128.6, 128.2, 127.1, 126.2, 116.9, 115.9, 115.8, 71.1, 51.8, 38.7, 36.3; 
IR (ATR) 3431, 2950, 1707, 1526, 1259, 1043, 801, 736, 697 cm-1; HRMS (ESI) calcd for 
C19H21N2O5 (M+H
+) 357.1450, found 357.1449.  
 
[2-(4-Benzyloxy-1H-indol-3-yl)-ethyl]-carbamic acid methyl ester (58) 
A solution of 57 (300 mg, 0.84 mmol), Pd(dba)2 (29 mg, 0.050 mmol), 1,3- 
bis(diphenylphosphino)propane (21 mg, 0.051 mmol), and 1,10-phenanthroline (18 mg, 0.1 
mmol) in anhydrous DMF (4 mL) in a Teflon screw-capped ACE-Glass pressure tube was 
saturated with carbon monoxide (4 cycles to 6 atm of CO). The reaction mixture was stirred 
under CO (6 atm) at 120 °C for 24 h. The mixture was cooled to ambient temperature, 
diluted with EtOAc (15 mL), and washed with brine (2x30 mL). The organic phase was 
dried (MgSO4) and filtered. The solvent was removed, and the resulting residue was purified 
by chromatography (hexanes/EtOAc, 2:1) to afford 58 (216 mg, 0.67 mmol, 79 %) as a 
white solid.  
Spectral data for 58: mp 97-98 oC; 1H NMR (400 MHz, CDCl3, 65 
oC)  8.25 (br s, 1H), 
7.51 (d, J = 7.5 Hz, 2H), 7.40-7.47 (m, 2H), 7.35-7.40 (m, 1H), 7.10 (t, J = 8.0 Hz, 1H), 6.98 
(d, J = 8.1 Hz, 1H), 6.83 (s, 1H), 6.61 (d, J = 7.7 Hz, 1H), 5.21 (s, 2H), 4.71 (br s, 1H), 3.65 
(s, 3H), 3.47 (q, J = 6.6 Hz, 2H), 3.08 (t, J = 6.7 Hz, 2H); 13C NMR(100 MHz, CDCl3)  
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157.1, 153.4, 138.2, 137.1, 128.5, 127.9, 127.5, 122.6, 121.4, 117.2, 112.9, 104.9, 100.2, 
69.8, 51.8, 42.5, 27.1; IR (ATR) 3412, 3319, 2944, 1698, 1505, 1251, 1071, 730 cm-1; 
HRMS (ESI) calcd for C19H21N2O3 (M+H
+) 325.1552, found 325.1549.  
 
[2-(4-Hydroxy-1H-indol-3-yl)-ethyl]-carbamic acid methyl ester (59) 
 A solution of 58 (478 mg, 1.47 mmol) and Pd/C (10 % wt., 57.4 mg, 0.054 mmol) in MeOH 
(19 mL) in a Teflon screw-capped ACE-Glass pressure tube was saturated with hydrogen (4 
cycles to 1.5 atm of H2). The reaction mixture was stirred under H2 (1.5 atm) at r.t. for 16 h. 
The solvent were removed on a rotary evaporator at water aspirator pressure. The mixture 
was diluted with EtOAc (20 mL), and washed with brine (2x20 mL). The organic phase was 
dried (MgSO4) and filtered. The solvent was removed, and the resulting residue was purified 
by chromatography (hexanes/EtOAc, 2:1) to afford 59 (286 mg, 1.22 mmol, 83 %) as a pink 
solid.  
Spectral data for 59: mp 165-167 oC; 1H NMR (400 MHz, d-DMSO)  10.58 (s, 1H), 9.28 (s, 
1H), 7.10 (t, J = 5.2 Hz, 1H), 6.89 (d, J = 2.2 Hz, 1H), 6.79 (dd, J = 8.1, 7.2 Hz, 1H), 6.75 
(dd, J = 8.1, 1.1 Hz, 1H), 6.29 (dd, J = 7.2, 1.2 Hz, 1H), 3.50 (s, 3H), 3.24-3.31 (m, 2H), 
2.92 (t, J = 7.4 Hz, 2H); 13C NMR(100 MHz, d-DMSO)  156.6, 151.7, 138.6, 121.7, 120.9, 
116.5, 111.9, 102.9, 102.7, 51.0, 42.2, 26.8; IR (ATR) 3396, 2971, 1739, 1454, 1366, 1217, 
1040, 737 cm-1; HRMS (ESI) calcd for C12H15N2O3 (M+H
+) 235.1083, found 235.1083.  
 
Trifluoro-methanesulfonic acid 3-(2-methoxycarbonylamino-ethyl)-1H-indol-4-yl ester 
(60) 
Trifluoromethanesulfonic anhydride (0.423 mL, 2.51 mmol) was added to a solution of 59 
(141 mg, 0.60 mmol) and triethylamine (1.7 mL, 12.20 mmol) in CH3CN (17 mL) at 0 
oC. 
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The mixture was warmed to room temperature and stirred for 3 h. The reaction was 
quenched with H2O (50 mL) and extracted with EtOAc (3x30 mL), dried (MgSO4) and the 
solvents were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 1:1) and then recrystallization (CH2Cl2/hexanes, 2:1) gave 
60 (120 mg, 0.33 mmol, 54 %,) as a yellow solid.  
Spectral data for 60: mp 105-106 oC; 1H NMR (400 MHz, CDCl3)   8.63 (br s, 1H), 7.36 (d, 
J = 8.1 Hz, 1H), 7.15 (t, J = 8.0 Hz, 1H), 7.01 (d, J = 7.8 Hz, 1H), 6.95 (s, 1H), 4.88 (br s, 
1H), 3.67 (s, 3H), 3.51 (q, J = 6.8 Hz, 2H), 3.07 (t, J = 7.2 Hz, 2H). 13C NMR (150 MHz, 
CDCl3)  157.3, 142.7, 139.1, 124.5, 121.9, 121.8, 119.7, 119.5, 117.5, 115.4, 111.8, 111.3, 
110.9, 52.1, 41.8, 26.4; IR (ATR) 3341, 2971, 1711, 1413, 1217, 1136, 1001, 865, 735 cm-1; 
HRMS (ESI) calcd for C13H14F3N2O5S (M+H
+) 367.0576, found 367.0581.  
 
2-Iodo-1-(4-methoxy-benzyloxy)-3-nitro-benzene (63) 
4-Methoxybenzyl chloride (1.04 mL, 7.67 mmol) was added to a solution of 2-iodo-3-
nitrophenol (2.00 g, 7.55 mmol) and potassium carbonate (1.14 g, 8.25 mmol) in CH3CN (40 
mL). The mixture was stirred under N2 at 80 
oC for 17 h. The reaction was quenched with 
H2O (80 mL) and extracted with EtOAc (3x60 mL), dried (MgSO4) and the solvents were 
removed on a rotary evaporator at water aspirator pressure. Purification by chromatography 
(hexanes/EtOAc, 10:1) gave 63 (2.64 g, 6.85 mmol, 91 %,) as a yellow solid.  
Spectral data for 63: mp 123-124 oC; 1H NMR (400 MHz, CDCl3)  7.39 (d, J = 8.8 Hz, 2H), 
7.36 (t, J = 8.1 Hz, 1H), 7.26 (dd, J = 8.1, 1.3 Hz, 1H), 7.00 (dd, J = 8.2, 1.3 Hz, 1H), 6.92 
(d, J = 8.8 Hz, 2H), 5.13 (s, 2H), 3.81 (s, 3H).  13C NMR(100 MHz, CDCl3)  159.5, 158.8, 
155.5, 129.8, 128.8, 127.4, 116.9, 115.2, 114.0, 80.8, 71.7, 55.2; IR (ATR) 3014, 2971, 1738, 
1515, 1374, 1218, 1012, 734 cm-1; HRMS (ESI) calcd for C14H12INNaO4 (M+Na
+) 
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407.9709, found 407.9704.  
 
[2-(4-Methoxy-benzyloxy)-6-nitro-phenyl]-trimethyl-stannane (64)  
Pd(PPh3)2Cl2 (79.3 mg, 0.11 mmol), hexamethylditin (1.94 g, 5.92 mmol) and 
triphenylphosphine (49 mg, 0.19 mmol) were added to a solution of 63 (1.52 g, 3.95 mmol) 
in toluene (33 mL) at room temperature. The mixture was stirred under N2 at 110 
oC for 18 h. 
The reaction was quenched with H2O (60 mL) and extracted with EtOAc (3x40 mL), dried 
(MgSO4) and the solvents were removed on a rotary evaporator at water aspirator pressure. 
Purification by chromatography (hexanes/EtOAc, 40:1) gave 64 (1.125 g, 2.67 mmol, 68 %) 
as a yellow solid.  
Spectral data for 64: mp 78.5-79 oC; 1H NMR (400 MHz, CDCl3)  7.70 (dd, J = 8.1, 0.8 Hz, 
1H), 7.36 (t, J = 8.1 Hz, 1H), 7.33 (d, J = 8.7 Hz, 2H), 7.11 (dd, J = 8.2, 0.6 Hz, 1H), 6.94 (d, 
J = 8.8 Hz, 2H), 5.02 (s, 2H), 3.83 (s, 3H), 0.27 (s, 9H); 13C NMR(100 MHz, CDCl3)  
164.0, 159.6, 155.9, 130.4, 129.6, 127.9, 127.8, 116.4, 115.3, 113.9, 70.7, 55.2, -5.6; IR 
(ATR) 3355, 2930, 1666, 1612, 1512, 1247, 1017, 861, 741 cm-1; HRMS (ESI) calcd for 
C17H21NNaO4Sn (M+Na
+) 446.0390, found 446.0385.  
 
{3-[2-(4-Methoxy-benzyloxy)-6-nitro-phenyl]-but-3-enyl}-carbamic acid methyl ester 
(65) 
A solution of 64 (3.3 g, 7.82 mmol), 51 (1.66 g, 6.51 mmol), Pd(dba)2 (187 mg, 0.33 mmol), 
triphenylphosphine (341.6 mg, 1.30 mmol), and copper (I) iodide (930.4 mg, 4.89 mmol) in 
DMF (116.5 mL) was stirred at r.t. for 22 h. The reaction was diluted with H2O (1 L) and 
extracted with EtOAc (3x300 mL), dried (MgSO4) and the solvents were removed on a 
rotary evaporator at water aspirator pressure. Purification by chromatography 
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(hexanes/EtOAc, 10:1, then hexanes/EtOAc, 5:1) gave 65 (2.05 g, 5.31 mmol, 81 %) as a 
yellow solid.  
Spectral data for 65: mp 77-77.5 oC; 1H NMR (600 MHz, CDCl3, 65 
oC)   7.29-7.34 (m, 
2H), 7.28 (d, J = 8.5 Hz, 2H), 7.13 (dd, J = 7.9, 1.3 Hz, 1H), 6.90 (d, J = 8.6 Hz, 2H), 5.21 (s, 
1H), 5.03 (s, 2H), 4.96 (s, 1H), 4.89 (br s, 1H), 3.80 (s, 3H), 3.60 (s, 3H), 3.31 (q, J = 6.4 Hz, 
2H), 2.95 (t, J = 6.4 Hz, 2H). 13C NMR (150 MHz, CDCl3, 65 
oC)  160.0, 156.9, 156.8, 
150.8, 140.0, 129.1, 128.6, 127.9, 126.8, 116.9, 116.3, 115.8, 114.4, 71.4, 55.3, 51.7, 39.1, 
36.6; IR (ATR) 2933, 1706, 1514, 1247, 1029, 817, 741 cm-1; HRMS (ESI) calcd for 
C20H22N2NaO6 (M+Na
+) 409.1376, found 409.1370.  
 
2-Iodo-1-methoxymethoxy-3-nitro-benzene (66) 
Chloromethyl methyl ether (8.68 mL, 114.28 mmol) was added to a solution of 2-iodo-3-
nitrophenol (13.41 g, 50.60 mmol) and potassium carbonate (28 g, 202.59 mmol) in DMF 
(73 mL). The mixture was stirred under N2 at room temperature for 1.5 h. The reaction was 
quenched with H2O (300 mL) and extracted with Ether (3x150 mL), dried (MgSO4) and the 
solvents were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 20:1) gave 66 (12.55 g, 40.61 mmol, 80 %) as a yellow 
solid.  
Spectral data for 66: mp 64-64.5 oC; 1H NMR (400 MHz, CDCl3)  7.37 (t, J = 7.7 Hz, 1H), 
7.29 (dd, J = 8.0, 1.4 Hz, 1H), 7.22 (dd, J = 8.2, 1.4 Hz, 1H), 5.28 (s, 2H), 3.49 (s, 3H); 13C 
NMR (100 MHz, CDCl3)  157.5, 155.3, 129.9, 117.7, 117.2, 95.2, 80.8, 56.6; IR (ATR) 
2937, 1535, 1458, 1375, 1254, 1152, 1002, 895 cm-1; HRMS (ESI) calcd for C8H9INO4 




Pd(PPh3)2Cl2 (402 mg, 0.57 mmol), hexamethylditin (9.38 g 28.63 mmol) and 
triphenylphosphine (235 mg, 0.90 mmol) were added to a solution of 66 (5.9 g, 19.09 mmol) 
in toluene (165 mL) at room temperature. The mixture was stirred under N2 at 110 
oC for 15 
h. The reaction was quenched with H2O (300 mL) and extracted with EtOAc (3x150 mL), 
dried (MgSO4) and the solvents were removed on a rotary evaporator at water aspirator 
pressure. Purification by chromatography (hexanes/EtOAc, 40:1) gave 67 (5.23 g, 15.12 
mmol, 79 %) as a red oil.  
Spectral data for 67: 1H NMR (400 MHz, CDCl3)  7.78 (dd, J = 7.8, 1.0 Hz, 1H), 7.40 (t, J 
= 8.1 Hz, 1H), 7.34 (dd, J = 8.2, 1.0 Hz, 1H), 5.19 (s, 2H), 3.48 (s, 3H), 0.36 (s, 9H); 13C 
NMR(100 MHz, CDCl3)  162.8, 155.6, 130.5, 128.0, 117.7, 117.4, 94.4, 56.2, -5.5; IR 
(ATR) 2976, 2907, 1522, 1345, 1242, 1148, 1008, 895, 739 cm-1; HRMS (ESI) calcd for 
C10H14NO4Sn (M-CH3
+) 331.9945, found 331.9942.  
 
[3-(2-Methoxymethoxy-6-nitro-phenyl)-but-3-enyl]-carbamic acid methyl ester (68) 
A solution of 67 (4.25 g, 12.30 mmol), 51 (2.61 g, 10.23 mmol), Pd(dba)2 (353.8 mg, 0.62 
mmol), triphenylphosphine (643 mg, 2.45 mmol), and copper (I) iodide (1.76 g, 9.24 mmol) 
in DMF (190 mL) was stirred at room temperature under N2 for 24 h. The reaction was 
diluted with H2O (1 L) and extracted with EtOAc (3x300 mL), dried (MgSO4) and the 
solvents were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (CH2Cl2 then hexanes/EtOAc, 2:1) gave 68 (2.50 g, 8.04 mmol, 79 %) as a 
yellow oil.  
Spectral data for 68: 1H NMR (600 MHz, CDCl3, 65 
oC)   7.39 (t, J = 4.6 Hz, 1H), 7.32 (d, 
J = 4.6 Hz, 2H), 5.25 (s, 1H), 5.19 (s, 2H), 5.03 (br s, 1H), 4.98 (s, 1H), 3.65 (s, 3H), 3.47 (s, 
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3H), 3.38 (q, J = 6.4 Hz, 2H), 2.68 (t, J = 6.4 Hz, 2H); 13C NMR (100 MHz, CDCl3)  156.5, 
154.4, 149.8, 139.7, 128.2, 126.2, 117.6, 116.0, 115.7, 94.3, 55.8, 51.2, 38.5, 35.7; IR (ATR) 
2955, 1708, 1526, 1252, 1152, 1006, 905, 727 cm-1; HRMS (ESI) calcd for C14H19N2O6 
(M+H+) 311.1243, found 311.1240. 
 
[3-(2-Hydroxy-6-nitro-phenyl)-but-3-enyl]-carbamic acid methyl ester (54)  
HCl (conc., 8.2 mL) was added to a solution of 68 (2.53 g, 8.15 mmol) in MeOH (82 mL) at 
room temperature. The mixture was stirred at room temperature for 23 h. The reaction was 
neutralized with NaHCO3 (aqueous, 100 mL) and extracted with EtOAc (3x100 mL), dried 
(MgSO4) and the solvents were removed on a rotary evaporator at water aspirator pressure. 
Purification by chromatography (hexanes/EtOAc, 4:1, then hexanes/EtOAc, 2:1) gave 54 
(1.80 g, 6.76 mmol, 83 %) as a yellow solid.  
Spectral data for 54: mp 121-121.5 oC; 1H NMR (600 MHz, CDCl3, 65 
oC)   7.49 (dd, J = 
8.1, 1.0 Hz, 1H), 7.29 (t, J = 8.2 Hz, 1H), 7.20 (dd, J = 8.2, 1.1 Hz, 1H), 7.06 (br s, 1H), 5.50 
(s, 1H), 5.19 (s, 1H), 4.97 (br s, 1H), 3.68 (s, 3H), 3.35 (q, J = 6.2 Hz, 2H), 2.60 (t, J = 6.2 
Hz, 2H); 13C NMR (150 MHz, CDCl3, 65 
oC)  157.9, 154.2, 149.2, 139.5, 128.7, 123.9, 
121.0, 119.2, 116.1, 52.3, 39.6, 37.7; IR (ATR) 3411, 1688, 1521, 1449, 1360, 1267, 818, 
737 cm-1; HRMS (ESI) calcd for C12H14N2NaO5 (M+Na
+) 289.0800, found 289.0795.  
 
Alternative synthesis of 54 
A solution of 2-iodo-3-nitrophenol (72 mg, 0.27 mmol), 44 (100 mg, 0.34 mmol), Pd(dba)2 
(3.12 mg, 0.0054 mmol), butylated hydroxytoluene (3.0 mg, 0.014 mmol), 
triphenylphosphine (5.7 mg, 0.022 mmol), and copper (I) iodide (52.8 mg, 0.28 mmol) in 
dioxane (5 mL) was stirred at 110 oC under N2 for 20 h. The reaction was diluted with H2O 
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(10 mL) and extracted with EtOAc (3x10 mL), dried (MgSO4) and the solvents were 
removed on a rotary evaporator at water aspirator pressure. Purification by chromatography 
(hexanes/EtOAc, 3:1) gave 54 (16 mg, 0.06 mmol, 22 %) as a yellow solid. 
 
Trifluoro-methanesulfonic acid 2-(3-methoxycarbonylamino-1-methylene-propyl)-3-
nitro-phenyl ester (53)  
Trifluoromethanesulfonic anhydride (0.41 mL, 2.44 mmol) was added to a solution of 54 
(599 mg, 2.25 mmol) and triethylamine (1.03 mL, 7.39 mmol) in CH3CN (10 mL) at 0 
oC. 
The mixture was warmed to room temperature and stirred for 2 h. The reaction was 
quenched with H2O (30 mL) and extracted with EtOAc (3x20 mL), dried (MgSO4) and the 
solvents were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 2:1) gave 53 (773 mg, 1.94 mmol, 86 %) as a yellow oil.  
Spectral data for 53: 1H NMR (600 MHz, CDCl3, 65 
oC)  7.85 (dd, J = 6.5, 2.8 Hz, 1H), 
7.52-7.56 (m, 2H), 5.47 (s, 1H), 5.19 (s, 1H), 4.89 (br s, 1H), 3.66 (s, 3H), 3.42 (q, J = 6.5 
Hz, 2H), 2.66 (t, J = 6.6 Hz, 2H). 13C NMR (150 MHz, CDCl3, 65 
oC)  160.0, 150.6, 147.2, 
137.1, 131.9, 129.4, 125.5, 123.7, 121.8, 120.1, 119.7, 117.5, 115.4, 51.9, 39.0, 36.3; IR 
(ATR) 3344, 1702, 1533, 1423, 1211, 1136, 947, 845 cm-1; HRMS (ESI) calcd for 
C13H13F3N2NaO7S (M+Na
+) 421.0293, found 421.0288.  
 
Alternative synthesis of 53 
A solution of 52 (34 mg, 0.086 mmol), 44 (30 mg, 0.10 mmol), Pd(PPh3)2Cl2 (3 mg, 0.0043 
mmol), triphenylphosphine (2.25 mg, 0.0086 mmol), and copper (I) iodide (12.2 mg, 0.064 
mmol) in DMF (1 mL) was stirred at room temperature under N2 for 26 h. The reaction was 
diluted with H2O (5 mL) and extracted with EtOAc (3x5 mL), dried (MgSO4) and the 
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solvents were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 5:1) gave 53 (7.5 mg, 0.019 mmol, 22 %) as a yellow oil. 
 
{3-[2-(3-Hydroxy-3-methyl-but-1-enyl)-6-nitro-phenyl]-but-3-enyl}-carbamic acid 
methyl ester (69)  
Pd(PPh3)2Cl2 (272.6 mg, 0.39 mmol), triethylamine (1.22 mL, 8.75 mmol), lithium chloride 
(247 mg, 5.83 mmol) and 2-methyl-3-buten-2-ol (2.03 mL, 19.42 mmol) were added to a 
solution of 53 (773 mg, 1.94 mmol) in DMF (41 mL) at room temperature. The mixture was 
stirred under N2 at 120 
oC for 14 h. The reaction was quenched with H2O (150 mL) and 
extracted with EtOAc (3x60 mL), dried (MgSO4) and the solvents were removed on a rotary 
evaporator at water aspirator pressure. Purification by chromatography (hexanes/EtOAc, 
2:1) gave 69 (355 mg, 1.06 mmol, 55 %) as a brown oil.  
Spectral data for 69: 1H NMR (600 MHz, CDCl3, 65 
oC)  7.67 (d, J = 7.9 Hz, 1H), 7.63 (d, 
J = 7.5 Hz, 1H), 7.35 (t, J = 7.9 Hz, 1H), 6.79 (d, J = 16.0 Hz, 1H), 6.31 (d, J = 16.0 Hz, 1H), 
5.31 (s, 1H), 5.03 (s, 1H), 4.93 (br s, 1H), 3.66 (s, 3H), 3.41 (br s, 2H), 2.61 (br s, 2H), 1.42 
(s, 6H); 13C NMR (150 MHz, CDCl3)  157.1, 149.9, 142.3, 141.8, 137.8, 135.2, 129.7, 
127.8, 122.9, 122.1, 115.8, 70.8, 52.2, 38.8, 36.3, 30.0, 29.3; IR (ATR) 3429, 2975, 1698, 
1525, 1359, 1265, 908, 658 cm-1; HRMS (ESI) calcd for C17H22N2NaO5 (M+Na
+) 357.1426, 
found 357.1415.  
 
{2-[4-(3-Methyl-buta-1,3-dienyl)-1H-indol-3-yl]-ethyl}-carbamic acid methyl ester (70) 
A solution of 69 (153 mg, 0.46 mmol), Pd(dba)2 (15.79 mg, 0.028 mmol), 1,3- 
bis(diphenylphosphino)propane (11.32 mg, 0.028 mmol) and 1,10-phenanthroline (9.9 mg, 
0.055 mmol) in anhydrous DMF (1.5 mL) in a Teflon screw-capped ACE-Glass pressure 
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tube was saturated with carbon monoxide (4 cycles to 6 atm of CO). The reaction mixture 
was stirred under CO (6 atm) at 120 °C for 24 h. The mixture was cooled to ambient 
temperature, diluted with EtOAc (10 mL), and washed with brine (2x10 mL). The organic 
phase was dried (MgSO4) and filtered. The solvent was removed, and the resulting residue 
was purified by chromatography (hexanes/EtOAc, 2:1) to afford 70 (67 mg, 0.24 mmol, 52 
%) as a yellow solid.  
Spectral data for 70: mp 129.5-130 oC; 1H NMR (600 MHz, CDCl3, 65 
oC)  7.93 (br s, 1H), 
7.11-7.22 (m, 3H), 7.06 (t, J = 7.7 Hz, 1H), 6.91 (s, 1H), 6.75 (d, J = 15.8 Hz, 1H), 5.04 (s, 
1H), 4.99 (s, 1H), 4.55 (br s, 1H), 3.56 (s, 3H), 3.43 (q, J = 6.3 Hz, 2H), 3.04 (t, J = 6.7 Hz, 
2H), 1.94 (s, 3H); 13C NMR (150 MHz, CDCl3)  157.0, 142.2, 137.3, 133.2, 131.5, 127.0, 
124.6, 123.3, 122.4, 117.1, 117.1, 113.3, 110.5, 52.0, 41.5, 28.1, 18.7; IR (ATR) 3387, 3295, 
2943, 1695, 1521, 1342, 1254, 1234, 963, 745 cm-1; HRMS (ESI) calcd for C17H20N2NaO2 




To a solution of 70 (42 mg, 0.15 mmol) in anhydrous toluene (14 mL) was added sodium 
bis(2-methoxyethoxy)aluminumhydride (in toluene ∼3.5 M, 0.94 mL, 3.29 mmol) dropwise. 
The mixture was stirred at 110 °C for 2 h and then allowed to cool to ambient temperature. 
Brine (30 mL) was added, and the mixture was extracted with EtOAc (5x20 mL). The 
organic phases were combined, dried (MgSO4), and filtered. The solvent was removed, and 
the resulting residue was purified by chromatography (1 % Et3N in EtOAc/MeOH, 5:1 ) to 
give dehydrated ergotryptamine (25.3 mg, 0.11 mmol, 71 %) as a yellow solid. 
Spectral data for dehydrated ergotryptamine: mp 157.5-158 oC; 1H NMR (600 MHz, 
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CDCl3)  8.04 (br s, 1H), 7.30 (d, J = 7.4 Hz, 1H), 7.29 (d, J = 15.8 Hz, 1H), 7.26 (d, J = 7.9 
Hz, 1H), 7.16 (t, J = 7.7 Hz, 1H), 7.05 (d, J = 2.1 Hz, 1H), 6.87 (d, J = 16.0 Hz, 1H), 5.13 (s, 
1H), 5.08 (s, 1H), 3.14 (t, J = 6.9 Hz, 2H), 2.94 (t, J = 6.8 Hz, 2H), 2.44 (s, 3H), 2.03 (s, 3H). 
13C NMR (150 MHz, CDCl3)  142.3, 137.3, 132.8, 131.5, 127.3, 124.8, 123.2, 122.3, 116.9, 
116.8, 114.3, 110.5, 52.2, 36.3, 28.1, 18.7; IR (ATR) 2935, 2851, 1608, 1450, 1343, 1103, 
962, 737 cm-1; HRMS (ESI) calcd for C16H21N2  (M+H
+) 241.1705, found 241.1699.  
 
{3-[2-(3-Methyl-buta-1,3-dienyl)-6-nitro-phenyl]-but-3-enyl}-carbamic acid methyl 
ester (71) 
Pyridinium p-toluenesulfonate (0.2 mg, 0.00081 mmol) was added to a solution of 69 (4.5 
mg, 0.014 mmol) in CHCl3 (0.8 mL) at room temperature. The mixture was stirred at 55 
oC 
for 22 h then cooled to room temperature. The solvent was removed on a rotary evaporator 
at water aspirator pressure. Purification by chromatography (hexanes/EtOAc, 3:1) gave 71 (3 
mg, 0.0095 mmol, 70 %) as a colorless oil. 
Spectral data for 71: 1H NMR (400 MHz, CDCl3)   7.77 (dd, J = 7.9, 0.9 Hz, 1H), 7.65 (dd, 
J = 8.1, 1.2 Hz, 1H), 7.38 (td, J = 8.0, 0.5 Hz, 1H), 6.83 (d, J= 16.1 Hz, 1H), 6.59 (d, J= 16.1 
Hz, 1H), 5.35 (s, 1H), 5.18 (s, 1H), 5.16 (s, 1H), 5.04 (s, 1H), 4.95 (br s, 1H), 3.66 (s, 3H), 
3.32-3.53 (m, 2H), 2.49-2.69 (m, 2H), 1.94 (s, 3H). 
 
5-Methylene-1-(2-methyl-propenyl)-6-nitro-1,3,4,5-tetrahydro-benzo[c]azepine-2-
carboxylic acid methyl ester (72)  
BF3.OEt2 (48 % BF3, 0.024 mL) was added to a solution of 69 (30 mg, 0.0897 mmol) in 
diethyl ether (3 mL) at -78 oC under N2. The mixture was stirred for 1.5 h at -78 
oC then 
warmed to room temperature and stirred for 1 h. Additional BF3.OEt2 (48 % BF3, 0.01 mL) 
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was added and the mixture was stirred for additional 0.5 h at room temperature. The reaction 
was quenched with Na2CO3.10H2O and dried (MgSO4). The mixture was filtered and the 
solvents were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 10:1) gave 72 (16 mg, 0.051 mmol, 56 %) as a yellow 
solid.  
Spectral data for major rotamer of 72: 1H NMR (600 MHz, d-DMSO, 75 oC)  7.67 (dd, J = 
7.9, 1.1 Hz, 1H), 7.49 (d, J = 7.1 Hz, 1H), 7.44 (t, J = 7.9 Hz, 1H), 5.88 (d, J = 6.2 Hz, 1H), 
5.50 (d, J = 8.2 Hz, 1H), 5.27 (s, 1H), 4.94 (s, 1H), 3.86-3.96 (m, 1H), 3.60 (s, 3H), 3.40 
(ddd, J = 14.3, 10.7, 3.9 Hz, 1H), 2.61 (td, J = 13.1, 3.8 Hz, 1H), 2.50-2.55 (m, 1H), 1.75 (s, 
3H), 1.69 (s, 3H).  
Spectral data for 72 as mixture of rotamers: mp 94-94.5 oC; 13C NMR (150 MHz, CDCl3, 65 
oC)  156.0, 151.4, 143.5, 142.0, 138.3, 135.0, 131.7, 127.5, 121.9, 121.3, 117.9, 59.1, 52.7, 
52.6, 43.5, 37.1, 25.6, 25.6, 18.3; IR (ATR) 2956, 1694, 1528, 1439, 1364, 1247, 912, 729 
cm-1; HRMS (ESI) calcd for C17H21N2O4 (M+H
+) 317.1501, found 317.1498.  
 
6-(2-Methyl-propenyl)-3,4-dihydro-1H,6H-azepino[5,4,3-cd]indole-5-carboxylic acid 
methyl ester (73) 
A solution of 72 (203 mg, 0.64 mmol), Pd(dba)2 (22 mg, 0.038 mmol), 1,3- 
bis(diphenylphosphino)propane (15.87 mg, 0.039 mmol), and 1,10-phenanthroline (13.84 
mg, 0.077 mmol) in anhydrous DMF (3.5 mL) in a Teflon screw-capped ACE-Glass 
pressure tube was saturated with carbon monoxide (4 cycles to 6 atm of CO). The reaction 
mixture was stirred under CO (6 atm) at 120 °C for 24 h. The mixture was cooled to ambient 
temperature, diluted with EtOAc (20 mL), and washed with brine (2x20 mL). The organic 
phase was dried (MgSO4) and filtered. The solvent was removed, and the resulting residue 
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was purified by chromatography (hexanes/EtOAc, 2:1) to afford 73 (138 mg, 0.49 mmol, 76 
%) as a yellow solid.  
Spectral data for 73 as mixture of rotamers: mp 180.5-181 oC; 1H NMR (600 MHz, CDCl3)  
8.12 (s, 0.5H), 8.09 (s, 0.5H), 7.22 (d, J = 8.1 Hz, 0.5H), 7.19 (d, J = 8.0 Hz, 0.5H), 7.11 (t, J 
= 7.4 Hz, 0.5H), 7.10 (t, J = 7.5 Hz, 0.5H), 7.00 (s, 0.5H), 6.98 (s, 0.5H), 6.87 (d, J = 7.3 Hz, 
0.5H), 6.82 (d, J = 7.3 Hz, 0.5H), 6.56 (d, J = 8.2 Hz, 0.5H), 6.36 (d, J = 8.0 Hz, 0.5H), 5.37 
(d, J = 8.6 Hz, 0.5H), 5.36 (d, J = 8.2 Hz, 0.5H), 4.08 (td, J = 13.9, 3.1 Hz, 0.5H), 3.95 (td, J 
= 14.1, 3.1 Hz, 0.5H), 3.73 (s, 1.5H), 3.71 (s, 1.5H), 3.50-3.60 (m, 1H), 3.30-3.38 (m, 0.5H), 
3.19-3.27 (m, 0.5H),  3.01-3.04 (m, 0.5H), 2.98-3.01 (m, 0.5H), 1.89 (s, 1.5H), 1.84 (s, 
1.5H), 1.72 (s, 3H); 13C NMR (150 MHz, CDCl3)  156.4, 155.8, 137.3, 137.2, 137.0, 136.0, 
135.7, 125.2, 124.2, 124.1, 121.9, 121.7, 121.4, 121.0, 118.3, 117.7, 114.7, 114.4, 109.3, 
109.1, 58.2, 58.1, 52.6, 52.5, 43.1, 42.8, 27.5, 26.6, 25.7, 25.7, 18.7, 18.4; IR (ATR) 3324, 
2956, 1676, 1439, 1406, 1319,  913, 746, 730 cm-1; HRMS (ESI) calcd for C17H20N2NaO2 
(M+Na+) 307.1422, found 307.1418.  
 
3-[2-(3-Methoxycarbonylamino-1-methylene-propyl)-3-nitro-phenyl]-acrylic acid 
methyl ester (74) 
Pd(PPh3)2Cl2 (90 mg, 0.13 mmol), triethylamine (0.40 mL, 2.89 mmol), lithium chloride 
(81.5 mg, 1.92 mmol) and methyl acrylate (0.57 mL, 6.37 mmol) were added to a solution of 
53 (255 mg, 0.64 mmol) in DMF (13.5 mL) at room temperature. The mixture was stirred 
under N2 at 120 
oC for 12 h. The reaction was quenched with H2O (80 mL) and extracted 
with EtOAc (3x30 mL), dried (MgSO4) and the solvents were removed on a rotary 
evaporator at water aspirator pressure. Purification by chromatography (hexanes/EtOAc, 
4:1) gave 74 (130 mg, 0.39 mmol, 61 %) as a brown oil.  
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Spectral data for 74: 1H NMR (600 MHz, CDCl3)  7.79-7.83 (m, 2H), 7.77 (d, J = 16.1 Hz, 
1H), 7.46 (t, J = 8.0 Hz, 1H), 6.42 (d, J = 16.0 Hz, 1H), 5.42 (s, 1H), 5.06 (s, 1H), 5.03 (br s, 
1H), 3.82 (s, 3H), 3.66 (s, 3H), 3.42 (q, J = 6.1 Hz, 2H), 2.58-2.67 (m, 1H), 2.49-2.58 (m, 
1H); 13C NMR(150 MHz, CDCl3)  166.5, 160.0, 149.9, 140.8, 140.4, 137.0, 135.0, 130.4, 
128.3, 124.9, 121.8, 117.9, 52.1, 52.0, 38.5, 37.3; IR (ATR) 3343, 2952, 1709, 1527, 1318, 
1245, 1174, 752 cm-1; HRMS (ESI) calcd for C16H18N2NaO6 (M+Na
+) 357.1063, found 
357.1058. 
 
3-[3-(2-Methoxycarbonylamino-ethyl)-1H-indol-4-yl]-acrylic acid methyl ester (75) 
A solution of 74 (121 mg, 0.36 mmol), Pd(dba)2 (12.46 mg, 0.022 mmol), 1,3- 
bis(diphenylphosphino)propane (8.95 mg, 0.022 mmol), and 1,10-phenanthroline (7.82 mg, 
0.043 mmol) in anhydrous DMF (1.4 mL) in a Teflon screw-capped ACE-Glass pressure 
tube was saturated with carbon monoxide (4 cycles to 6 atm of CO). The reaction mixture 
was stirred under CO (6 atm) at 120 °C for 28 h. The mixture was cooled to ambient 
temperature, diluted with EtOAc (10 mL), and washed with brine (2x10 mL). The organic 
phase was dried (MgSO4) and filtered. The solvent was removed, and the resulting residue 
was purified by chromatography (hexanes/EtOAc, 2:1) to afford 75 (91 mg, 0.30 mmol, 83 
%) as a yellow oil.  
Spectral data for 75: 1H NMR (600 MHz, CDCl3)  8.63 (br s, 1H), 8.43 (d, J = 15.8 Hz, 1H), 
7.39 (d, J = 8.0 Hz, 1H), 7.37 (d, J = 7.4 Hz, 1H), 7.17 (t, J = 7.8 Hz, 1H), 7.06 (s, 1H), 6.45 
(d, J = 15.8 Hz, 1H), 5.09 (br s, 1H), 3.83 (s, 3H), 3.67 (s, 3H), 3.52 (q, J = 6.5 Hz, 2H), 
3.13 (t, J = 7.0 Hz, 2H); 13C NMR (100 MHz, CDCl3)  167.8, 157.2, 143.5, 137.4, 127.6, 
125.4, 124.4, 122.0, 118.2, 118.1, 113.3, 113.0, 52.0, 51.7, 41.3, 28.2; IR (ATR) 3329, 3212, 
2948, 1689, 1526, 1251, 1161, 1042, 977, 746, 727 cm-1; HRMS (ESI) calcd for 
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C16H18N2NaO4 (M+Na
+) 325.1164, found 325.1159.  
 
{2-[4-(3-Hydroxy-3-methyl-but-1-enyl)-1H-indol-3-yl]-ethyl}-carbamic acid methyl 
ester (61)  
Methylmagnesium bromide (3.0 M in diethyl ether, 0.38 mL, 1.13 mmol) was added to a 
solution of 75 (34 mg, 0.11 mmol) in THF (4 mL) at 0 oC under N2. The mixture was 
warmed to room temperature and stirred for 1 h. The reaction was quenched with H2O (10 
mL) and extracted with EtOAc (3x10 mL), dried (MgSO4) and the solvents were removed 
on a rotary evaporator at water aspirator pressure. Purification by chromatography 
(hexanes/EtOAc, 2:1) gave 61 (13.2 mg, 0.044 mmol, 39 %) as a yellow solid.  
Spectral data for 61: mp 100-100.5 oC; 1H NMR (400 MHz, CDCl3)   8.09 (br s, 1H), 7.41 
(d, J = 15.7 Hz, 1H), 7.25 (d, J = 6.7 Hz, 1H), 7.11-7.21 (m, 2H), 7.00 (s, 1H), 6.32 (d, J = 
15.7 Hz, 1H), 5.04 (br s, 1H), 3.68 (s, 3H), 3.36-3.47 (m, 2H), 3.05-3.13 (m, 2H), 1.45 (s, 
6H); 13C NMR (100 MHz, CDCl3)  157.2, 140.4, 137.1, 131.7, 124.6, 124.2, 123.2, 122.3, 
117.5, 113.4, 110.2, 70.9, 52.2, 43.0, 30.0, 28.8; IR (ATR) 3392, 2967, 1701, 1525, 1264, 
1148, 969, 748 cm-1; HRMS (ESI) calcd for C17H22N2NaO3 (M+Na
+) 325.1528, found 
325.1526.  
 
Acetic acid 1,4-dimethyl-2,5-dioxo-pyrrolidin-3-yl ester (86) 
A mixture of 2-hydroxy-3-methyl-succinic acid (83) (200 mg, 1.35 mmol) and AcCl (0.79 
mL) was heated at 45 ºC for 1 h, then another 0.51 mL of AcCl was added and heated for 
another 4 h. The solvent was removed on a rotary evaporator at water aspirator pressure, and 
the residue was dissolved in CH2Cl2 (3 mL) and cooled to -78 ºC. To this was added a 
solution of methylamine (2.0 M in THF, 0.83 mL) at -78 ºC. The resulting mixture was 
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allowed to warm to room temperature and stirred overnight. The solvents were removed on a 
rotary evaporator at water aspirator pressure and AcCl (1.7 mL) was added. The resulting 
mixture stirred at 50 ºC for 11 h. The AcCl was removed and purification by 
chromatography (hexanes/EtOAc, 4:1) gave 86 (165 mg, 0.89 mmol, 66 %, dr = 15:1) as a 
colorless oil. 
Spectral data for major isomer of 86: 1H NMR (400 MHz, CDCl3)  5.58 (d, J = 8.4 Hz, 1H), 
3.11 (pent, J = 7.8 Hz, 1H), 2.99 (s, 3H), 2.15 (s, 3H), 1.14 (d, J = 7.6 Hz, 3H). 
Partial spectral data for minor isomer of 86: 1H NMR (400 MHz, CDCl3)  5.13 (d, J = 5.2 
Hz, 1H), 2.75-2.82 (m, 1H), 1.39 (d, J = 7.5 Hz, 3H). 
 
Acetic acid 3-acetoxy-1,4-dimethyl-5-oxo-pyrrolidin-2-yl ester (82) 
To a solution of 86 (400 mg, 2.16 mmol) in MeOH (5 mL) was added sodium borohydride 
(122.72 mg, 3.24 mmol) in one portion at -40 ºC. After stirring for 10 min at -40 ºC, 
saturated NH4Cl (10 mL) was added and the solution was extracted with EtOAc (4x10 mL). 
The combined organic phases were dried (MgSO4), filtered, and the solvents were removed 
on a rotary evaporator at water aspirator pressure giving crude product as a white solid. The 
product was dissolved in CH2Cl2 (3.75 mL) and added DMAP (14.67 mg, 0.12 mmol). The 
mixture was cooled to 0 ºC and added acetic anhydride (0.34 mL, 3.59 mmol) followed by 
triethylamine (0.5 mL, 3.58 mmol). Then the mixture was warmed to room temperature and 
stirred for 2.5 h. Brine (15 mL) was added, and the solution was extracted by EtOAc (3x15 
mL). The combined organic phases were dried (MgSO4), filtered, and the solvents were 
removed on a rotary evaporator at water aspirator pressure. Purification by chromatography 
(hexanes/EtOAc, 2:1) gave 82 (146 mg, 0.64 mmol, 29 %) as a colorless oil.  
Spectral data for 82: 1H NMR (400 MHz, CDCl3)  6.24 (d, J = 5.4 Hz, 1H), 5.28 (dd, J = 
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8.2, 5.3 Hz, 1H), 2.82 (s, 3H), 2.70 (pent, J = 7.8 Hz, 1H), 2.06 (s, 3H), 2.04 (s, 3H), 1.17 (d, 
J = 7.6 Hz, 3H). 
 
Acetic acid 2-(2-bromo-allyl)-1,4-dimethyl-5-oxo-pyrrolidin-3-yl ester (81) 
A solution of 82 (121 mg, 0.53 mmol) and 2-bromo-2-propen-1-yl trimethylsilane (13) (365 
μL, 2.12 mmol) in CH2Cl2 (2.74 mL) was cooled to -78 °C and stirred for 15 min. A solution 
of TiCl4 (116.4 μL, 1.06 mmol) in CH2Cl2 (1.37 mL) was added slowly. The cold bath was 
removed after 30 min, and the mixture was stirred at ambient temperature for an additional 1 
h. Na2CO3·10H2O (1.76 g) was added slowly. After stirring for 30 min, the mixture was 
dried (MgSO4) and filtered, and the solvent was removed. Purification by chromatography 
(hexanes/EtOAc, 2:1) gave 81 (144 mg, 0.50 mmol, 94 %) as a colorless oil. 
Spectral data for 81: 1H NMR (400 MHz, CDCl3)  5.71-5.74 (m, 1H), 5.57 (d, J = 2.0 Hz, 
1H), 5.20 (d, J = 6.2 Hz, 1H), 3.65-3.71 (m, 1H), 2.89 (d, J = 0.8 Hz, 3H), 2.67-2.78 (m, 2H), 
2.59 (ddd, J = 14.6, 7.3, 0.9 Hz, 1H), 2.07 (s, 3H), 1.10 (d, J = 7.4 Hz, 3H); 13C NMR (100 
MHz, CDCl3)  174.2, 170.2, 128.2, 120.7, 73.1, 63.5, 42.3, 38.5, 28.7, 20.7, 8.7. 
 
Acetic acid 1,4-dimethyl-5-oxo-2-(2-trimethylstannanyl-allyl)-pyrrolidin-3-yl ester (87) 
A solution of 81 (30 mg, 0.10 mmol), Pd(dba)2 (4.44 mg, 0.0078 mmol), hexamethylditin 
(67.78 mg, 0.21 mmol), triphenylphosphine (5.43 mg, 0.021 mmol) and DIPEA (3.6 L, 
0.021 mmol) in benzene (0.6 mL) was stirred at 80 °C for 4 h. The mixture was cooled to 
ambient temperature and purified by chromatography (hexanes/EtOAc, 2:1) to afford 87 (26 
mg, 0.07 mmol, 67 %) as a yellow oil.  
Spectral data for 87: 1H NMR (400 MHz, CDCl3)  5.77 (d, J = 1.2 Hz, 1H), 5.35 (d, J = 1.9 
Hz, 1H), 5.20 (d, J = 6.1 Hz, 1H), 3.38 (dd, J = 9.4, 4.7 Hz, 1H), 2.87 (s, 3H), 2.65-2.76 (m, 
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2H), 2.26 (dd, J = 14.0, 9.6 Hz, 1H), 2.04 (s, 3H), 1.08 (d, J = 7.4 Hz, 3H), 0.17 (s, 9H). 
 
Acetic acid 2-{2-[2-(4-methoxy-benzyloxy)-6-nitro-phenyl]-allyl}-1,4-dimethyl-5-oxo-
pyrrolidin-3-yl ester (80) 
A solution of 81 (16 mg, 0.055 mmol), 64 (28 mg, 0.066 mmol), Pd(dba)2 (1.6 mg, 0.0028 
mmol), triphenylphosphine (2.89 mg, 0.011 mmol), and copper (I) iodide (7.88 mg, 0.041 
mmol) in DMF (1 mL) was stirred at room temperature for 22 h. The reaction was diluted 
with H2O (5 mL) and extracted with EtOAc (3x5 mL), dried (MgSO4) and the solvents were 
removed on a rotary evaporator at water aspirator pressure. Purification by chromatography 
(hexanes/EtOAc, 10:1, then hexanes/EtOAc, 2:1) gave 80 (15.6 mg, 0.033 mmol, 60 %) as a 
yellow oil.  
Spectral data for 80: 1H NMR (400 MHz, CDCl3)  7.37 (d, J = 3.6 Hz, 1H), 7.37 (d, J = 5.7 
Hz, 1H), 7.30 (d, J = 8.6 Hz, 2H), 7.16 (dd, J = 5.7, 3.7 Hz, 1H), 6.91 (d, J = 8.7 Hz, 2H), 
5.36 (d, J = 5.8 Hz, 1H), 5.23 (s, 1H), 5.05 (d, J = 11.2 Hz, 1H), 5.03 (s, 1H), 5.00 (d, J = 
11.1 Hz, 1H), 3.82 (s, 3H), 3.67 (dd, J = 11.1, 3.1 Hz, 1H), 2.70-2.86 (m, 4H), 2.38 (br s, 
2H), 2.03 (s, 3H), 0.96 (d, J = 5.3 Hz, 3H).  
 
5-{2-[2-(4-Methoxy-benzyloxy)-6-nitro-phenyl]-allylidene}-1,3-dimethyl-1,5-dihydro-
pyrrol-2-one (89) and tricyclic compound 90 
To a solution of 80 (15 mg, 0.032 mmol) in toluene (0.65 mL) was added DBU (5.27 L, 
0.035 mmol). The mixture was stirred at 110 °C for 12 h, then cooled to room temperature. 
Purification by chromatography (hexanes/EtOAc, 3:1) gave 89 (1.4 mg, 0.0034 mmol, 11 %) 
followed by 90 (0.4 mg, 0.0011 mmol, 3 %), then (hexanes/EtOAc, 2:1) gave 80 (3.7 mg, 
0.0079 mmol, 25 %).   
103  
Spectral data for 89: 1H NMR (600 MHz, CDCl3)  7.46 (dd, J = 8.2, 1.4 Hz, 1H), 7.43 (t, J 
= 8.0 Hz, 1H), 7.18 (dd, J = 7.9, 1.3 Hz, 1H), 7.14 (d, J = 8.5 Hz, 2H), 6.81 (d, J = 8.7 Hz, 
2H), 6.10 (s, 1H), 6.05-6.07 (m, 1H), 5.48 (s, 1H), 5.12 (s, 1H), 5.01 (s, 2H), 3.79 (s, 3H), 
3.14 (s, 3H), 1.78 (d, J = 1.2 Hz, 3H).  
Spectral data for 90: 1H NMR (600 MHz, CDCl3)  7.37 (d, J = 8.5 Hz, 2H), 7.01 (t, J = 8.1 
Hz, 1H), 6.92 (d, J = 8.5 Hz, 2H), 6.62 (d, J = 1.6 Hz, 1H), 6.43 (d, J = 8.2 Hz, 1H), 6.21 (d, 
J = 8.1 Hz, 1H), 6.01 (d, J = 1.0 Hz, 1H), 5.15 (s, 1H), 5.03 (s, 2H), 3.82 (s, 3H), 2.89 (s, 
3H), 2.84 (d, J = 13.4 Hz, 1H), 2.49 (d, J = 13.2 Hz, 1H), 1.89 (d, J = 1.2 Hz, 3H).   
 
N-Allyl-2-methyl-N-(1-phenyl-ethyl)-acrylamide (92) 
To a solution of sodium hydride (60 % dispersion in mineral oil, 3.47 g, 144.58 mmol) in 
DMF (44 mL) was added 91 (8.22 g, 43.42 mmol) in DMF (46 mL) dropwisely at 0 °C. 
After addition, the mixture was warmed to room temperature and stirred for 30 min. Then 
the mixture was cooled to 0 °C and added allyl bromide (6.16 mL, 71.18 mmol) in DMF (44 
mL) slowly. Then the mixture was warmed to room temperature again and stirred for 1 h; 
brine (200 mL) was added, and the mixture was extracted with EtOAc (3x150 mL). The 
combined organic phases were dried (MgSO4) and filtered, and the solvent was removed at 
reduced pressure. Purification by chromatography (hexanes/EtOAc, 10:1) gave 92 (5.65 g, 
24.60 mmol, 57 %) as a pale yellow oil. 
Spectral data for 92: 1H NMR (400 MHz, CDCl3, 65 °C) δ 7.21-7.33 (m, 5H), 5.62-5.76 (m, 
1H), 5.58 (s, 1H), 5.13 (s, 1H), 5.08 (s, 1H), 4.99 (s, 1H), 4.95 (s, 1H), 3.98 (dd, J = 16.0, 
4.0 Hz, 1H), 3.50 (dd, J = 16.0, 5.6 Hz, 1H), 1.99 (s, 3H), 1.58 (d, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 172.5, 141.2, 140.6, 135.2, 128.2, 127.1, 126.9, 115.8, 114.2, 54.1, 
45.6, 20.3, 17.6; IR (ATR) 2978, 1619, 1451, 1409, 1201, 910, 697 cm-1; [α]25D = -106.6 ± 
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0.1 (c 1.0, CHCl3); HRMS (ESI) calcd for C15H20NO (M+H
+) 230.1545, found 230.1538. 
 
3-Methyl-1-(1-phenyl-ethyl)-1,5-dihydro-pyrrol-2-one (93) 
To a solution of 92 (288 mg, 1.26 mmol) in anhydrous CH2Cl2 (43 mL) was added Grubbs 
catalyst, 1st generation (103.3 mg, 0.13 mmol). The mixture was stirred at 45 °C for 13 h 
and then allowed to cool to ambient temperature. The solvent was removed at reduced 
pressure and the resulting residue was purified by chromatography (hexanes/EtOAc = 5:1) to 
give 93 (220 mg, 1.09 mmol, 87 %) as a brown solid. 
Spectral data for 93: mp 67.5-68.5 °C; 1H NMR (400 MHz, CDCl3) δ 7.25-7.34 (m, 4H), 
7.18-7.24 (m, 1H), 6.60 (d, J = 1.3 Hz, 1H), 5.54 (q, J = 7.1 Hz, 1H), 3.76 (td, J = 19.7, 1.7 
Hz, 1H), 3.45 (td, J = 19.6, 1.7 Hz, 1H), 1.90 (d, J = 1.7 Hz, 3H), 1.57 (d, J = 7.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 171.0, 140.7, 134.9, 134.9, 134.8, 128.0, 126.8, 126.4, 48.8, 
46.0, 17.2, 10.8; IR (ATR) 3425, 2986, 1663, 1452, 1402, 1224, 819, 790, 762, 700, 678 
cm1; HRMS (ESI) calcd for C13H16NO (M+H
+) 202.1232, found 202.1225. 
 
5-Hydroxy-3-methyl-1-(1-phenyl-ethyl)-1,5-dihydro-pyrrol-2-one (94) 
To a solution of LDA (1.5 M in tetrahydrofuran/ethylbenzene/heptane, 0.19 mL) in THF 
(0.85 mL) was added a solution of 93 (57 mg, 0.28 mmol) in THF (1.02 mL) at 0 °C. The 
mixture was stirred at 0 °C for 3 h, then charged in O2 and stirred for additional 30 min. The 
reaction was quenched by NH4Cl (5 mL), then warmed to room temperature and extracted 
by EtOAc (3x5 mL). The organic phase was dried (MgSO4) and filtered. The solvent was 
removed, and the resulting residue was purified by chromatography (hexanes/EtOAc, 4:1) to 
give 94 (30 mg, 0.14 mmol, 49 %) as a colorless oil. 
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Spectral data for the major isomer of 94: 1H NMR (400 MHz, CDCl3) δ 7.17-7.50 (m, 5H), 
6.46 (d, J = 1.6 Hz, 1H), 5.43 (d, J = 9.7 Hz, 1H), 5.17 (q, J = 7.2 Hz, 1H), 2.70 (d, J = 10.0 
Hz, 1H), 1.84 (s, 3H), 1.74 (d, J = 7.3 Hz, 3H).  
Partial spectral data for the minor isomer of 94: 1H NMR (400 MHz, CDCl3) δ 6.36-6.39 (m, 
1H), 5.33 (q, J = 7.4 Hz, 1H), 5.06 (d, J = 10.4 Hz, 1H), 2.96 (d, J = 10.6 Hz, 1H), 1.84 (s, 
3H), 1.72 (d, J = 7.3 Hz, 3H).   
Spectral data for mixture of both isomers of 94: IR (ATR) 3339, 2923, 1676, 1653, 1449, 





A solution of 94 (105 mg, 0.48 mmol) and 2-bromo-2-propen-1-yl trimethylsilane (13) 
(334 μL, 1.94 mmol) in CH2Cl2 (7.8 mL) was cooled to -78 °C and stirred for 15 min. 
TiCl4 (106 L, 0.97 mmol) was added slowly under a N2 atmosphere. The cold bath was 
removed after 30 min, and the mixture was stirred at ambient temperature for an additional 
1 h. Na2CO3·10H2O (1.67 g) was added slowly. After stirring for 30 min, the mixture was 
dried (MgSO4) and filtered. The solvents were removed and the crude product was purified 
by chromatography on silica gel (hexanes/EtOAc, 10:1) to give 95 (119 mg, 0.37 mmol, 
77 %, dr = 3:1) as a colorless oil. 
Spectral data for the major isomer of 95: 1H NMR (400 MHz, CDCl3) δ 7.19-7.47 (m, 5H), 
6.70 (s, 1H), 5.40-5.52 (m, 3H), 4.32-4.44 (m, 1H), 2.46 (dd, J = 14.0, 3.9 Hz, 1H), 1.92 (s, 
3H), 1.88 (dd, J = 13.9, 10.6 Hz, 1H), 1.73 (d, J = 7.3 Hz, 3H). 
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Partial spectral data for the minor isomer of 95: 1H NMR (400 MHz, CDCl3) δ 6.64 (s, 1H), 
5.37 (q, J = 7.4 Hz, 1H), 3.95-4.03 (m, 1H), 3.00 (dd, J = 13.6, 4.0 Hz, 1H), 2.25 (dd, J = 
13.5, 10.7 Hz, 1H), 1.90 (d, J = 1.2 Hz, 3H). 1.69 (d, J = 7.2 Hz, 3H). 
Spectral data for the mixture of both isomers of 95: 13C NMR (100 MHz, CDCl3) δ 171.9, 
171.8, 141.6, 140.1, 139.3, 139.3, 139.2, 139.2, 134.8, 134.7, 128.7, 128.4, 128.3, 128.2, 
127.3, 127.1, 127.1, 126.8, 119.6, 58.4, 57.3, 51.4, 49.3, 44.4, 44.1, 18.5, 17.1, 11.0, 11.0;  
IR (ATR) 2975, 1677, 1397, 1229, 894, 836, 754, 699 cm-1; HRMS (ESI) calcd for 
C16H19BrNO (M+H




A solution of 95 (106 mg, 0.33 mmol), 67 (137.43 mg, 0.40 mmol), Pd(dba)2 (9.52 mg, 
0.017 mmol), triphenylphosphine (17.35 mg, 0.066 mmol), and copper (I) iodide (47.3 mg, 
0.25 mmol) in DMF (6 mL) was stirred at room temperature for 24 h. The reaction was 
diluted with H2O (15 mL) and extracted with EtOAc (3x15 mL), dried (MgSO4) and the 
solvents were removed on a rotary evaporator at water aspirator pressure. Purification by 
chromatography (hexanes/EtOAc, 2:1) gave 96 (105 mg, 0.25 mmol, 75 %, dr = 3:1) as a 
yellow oil.  
Spectral data for the major isomer of 96: 1H NMR (400 MHz, CDCl3, 65 °C) δ 7.13-7.36 
(m, 8H), 6.83 (s, 1H), 5.28 (q, J = 7.2 Hz, 1H), 5.17 (s, 1H), 4.98-5.09 (m, 2H), 4.96 (s, 
1H), 4.21 (d, J = 11.5 Hz, 1H), 3.33 (s, 3H), 2.79 (d, J = 14.7 Hz, 1H), 1.91 (dd, J = 14.8, 
11.7 Hz, 1H), 1.88 (s, 3H), 1.64 (d, J = 7.3 Hz, 3H). 
Spectral data for the minor isomer of 96: 1H NMR (400 MHz, CDCl3, 65 °C) δ 7.13-7.36 
(m, 8H), 6.78 (s, 1H), 5.33 (q, J = 7.3 Hz, 1H), 5.11 (s, 1H), 4.98-5.09 (m, 2H), 4.92 (s, 
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1H), 3.81 (d, J = 10.5 Hz, 1H), 3.36 (s, 3H), 3.19 (d, J = 14.8 Hz, 1H), 2.19 (dd, J = 14.4, 
11.6 Hz, 1H), 1.88 (s, 3H), 1.67 (d, J = 7.3 Hz, 3H). 
Spectral data for the mixture of both isomers of 96: HRMS (ESI) calcd for C24H27N2O5 




To a stirred solution of the 96 (29 mg, 0.069 mmol) in CH2Cl2 (0.75 mL) was added 
activated (while hot) NaHSO4.SiO2 (27.5 mg, 0.15 mmol) (the catalyst was kept in an oven 
at 120 °C for 48 h before using it) at room temperature. After completion of the reaction 
(monitored by TLC, overnight), the catalyst was filtered off and washed with CH2Cl2 (2x2 
mL). The filtrate and washings were combined, and the solvents were removed under 
vacuum. Purification by chromatography (hexanes/EtOAc, 1:1) gave 97 (24 mg, 0.063 
mmol, 92 %, dr = 3:1) as a colorless oil.   
Spectral data for the major isomer of 97: 1H NMR (600 MHz, CDCl3, 65 °C) δ 7.11-7.43 
(m, 8H), 6.70 (s, 1H), 5.25 (q, J = 7.2 Hz, 1H), 5.16 (s, 1H), 5.05 (s, 1H), 4.18 (d, J = 10.0 
Hz, 1H), 2.77 (d, J = 14.8 Hz, 1H), 2.10 (dd, J = 14.0, 11.2 Hz, 1H), 1.80 (s, 3H), 1.65 (d, 
J = 7.3 Hz, 3H). 
Spectral data for the minor isomer of 97: 1H NMR (600 MHz, CDCl3, 65 °C) δ 7.11-7.43 
(m, 8H), 6.73 (s, 1H), 5.31 (q, J = 7.1 Hz, 1H), 5.23 (s, 1H), 5.06 (s, 1H), 3.81 (d, J = 10.7 
Hz, 1H), 3.16 (d, J = 14.3 Hz, 1H), 2.29 (dd, J = 12.8, 11.6 Hz, 1H), 1.82 (s, 3H), 1.66 (d, 





1H-pyrrol-2-ylmethyl]-vinyl}-3-nitro-phenyl ester (98) 
N-Phenyl-bis(trifluoromethanesulfonimide) (23 mg, 0.064 mmol) was added to a solution of 
97 (24 mg, 0.063 mmol) and K2CO3 (13 mg, 0.094 mmol) in DMF (0.35 mL). The mixture 
was stirred at room temperature for 30 min. The reaction was diluted with H2O (2 mL) and 
extracted with EtOAc (3x2 mL), dried (MgSO4) and the solvents were removed on a rotary 
evaporator at water aspirator pressure. Purification by chromatography (hexanes/EtOAc, 
2:1) gave 98 (31 mg, 0.061 mmol, 96 %, dr = 3:1) as a yellow oil.  
Spectral data for major isomer of 98: 1H NMR (600 MHz, CDCl3, 65 
oC) δ 7.84 (d, J = 6.8 
Hz, 1H), 7.52 (t, J = 8.3 Hz, 1H), 7.48-7.51 (m, 1H), 7.34 (d, J = 7.4 Hz, 2H), 7.24 (d, J = 
7.7 Hz, 2H), 7.15-7.18 (m, 1H), 6.84 (s, 1H), 5.41 (s, 1H), 5.35 (q, J = 7.3 Hz, 1H), 5.18 (s, 
1H), 4.25 (d, J = 11.2 Hz, 1H), 2.63 (d, J = 13.0 Hz, 1H), 1.91 (t, J = 1.7 Hz, 3H), 1.84 (dd, 
J = 15.9, 11.3 Hz, 1H), 1.66 (d, J = 7.3 Hz, 3H). 
Spectral data for minor isomer of 98: 1H NMR (600 MHz, CDCl3, 65 
oC) δ 7.46-7.50 (m, 
1H), 7.30-7.32 (m, 1H), 7.21-7.26 (m, 3H), 7.15-7.20 (m, 2H), 7.11 (t, J = 7.3 Hz, 1H), 6.80 
(t, J = 1.4 Hz, 1H), 5.37 (q, J = 7.3 Hz, 1H), 5.35 (s, 1H), 5.16 (s, 1H), 3.79 (d, J = 11.2 Hz, 
1H), 3.10 (d, J = 10.8 Hz, 1H), 2.18 (t, J = 12.9 Hz, 1H), 1.90 (t, J = 1.7 Hz, 3H), 1.67 (d, J 
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Tetrahedron 2003, 59, 5507-5514. (g) Söderberg, B. C.; Chisnell, A. C.; 
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W.; Rector, S. R.; O’Neil, S. N. Tetrahedron 2005, 61, 3637−3649. (d) Lee, T. 
S.; Das, A.; Khosla, C. Bioorg. Med. Chem. 2007, 15, 5207−5218. 
18. For examples of the more unusual 8-endo-trig cyclization, see (a) Majumdar, 
K. C.; Chattopadhyay, B.; Sinha, B. Synthesis 2008, 3857−3863. (b) Jäger, M.; 
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H NMR (60 °C) of tricyclic compound 11 
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H NMR of 3-(t-butyl-dimethyl-silanyloxy)-2-methoxy-pyrrolidine-1-carboxylic 






C NMR of 3-(t-butyl-dimethyl-silanyloxy)-2-methoxy-pyrrolidine-1-carboxylic 




Figure 45: 1H NMR (65 °C) of 2-(2-bromo-allyl)-3-(t-butyl-dimethyl-silanyloxy)-






C NMR (65 °C) of 2-(2-bromo-allyl)-3-(t-butyl-dimethyl-silanyloxy)-



























































H NMR (65 °C) of 2(R/S)-(2-bromo-2-propen-1-yl)-3(R)-t-butyldimethyl- 













































































































Figure 72: 13C NMR of [3-(2-bromo-6-nitro-phenyl)-but-3-enyl]-carbamic acid  






































H NMR (65 oC) of [3-(2-benzyloxy-6-nitro-phenyl)-but-3-enyl]-carbamic acid 




Figure 80: 13C of [3-(2-benzyloxy-6-nitro-phenyl)-but-3-enyl]-carbamic acid  






H NMR (65 oC) of [2-(4-benzyloxy-1H-indol-3-yl)-ethyl]-carbamic acid  






C NMR of [2-(4-benzyloxy-1H-indol-3-yl)-ethyl]-carbamic acid  










































































H NMR of [2-(4-methoxy-benzyloxy)-6-nitro-phenyl]-trimethyl-stannane (64) 
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H NMR (65 oC ) of {3-[2-(4-methoxy-benzyloxy)-6-nitro-phenyl]-but-3- 






C NMR (65oC) of {3-[2-(4-methoxy-benzyloxy)-6-nitro-phenyl]-but-3- 


























H NMR (65oC) of [3-(2-methoxymethoxy-6-nitro-phenyl)-but-3-enyl]-carbamic 





C NMR of [3-(2-methoxymethoxy-6-nitro-phenyl)-but-3-enyl]-carbamic acid 





H NMR (65 oC) of [3-(2-hydroxy-6-nitro-phenyl)-but-3-enyl]-carbamic acid  






C NMR (65 oC) of [3-(2-hydroxy-6-nitro-phenyl)-but-3-enyl]- 






H NMR (65 oC) of trifluoro-methanesulfonic acid 2-(3-methoxy- 






C NMR (65 oC) of trifluoro-methanesulfonic acid 2-(3-methoxy- 






H NMR (65 oC) of {3-[2-(3-hydroxy-3-methyl-but-1-enyl)-6-nitro-phenyl]- 






C NMR of {3-[2-(3-hydroxy-3-methyl-but-1-enyl)-6-nitro-phenyl]-but- 3-






H NMR (65 oC) of {2-[4-(3-methyl-buta-1,3-dienyl)-1H-indol-3-yl]-ethyl}- 





C NMR of {2-[4-(3-methyl-buta-1,3-dienyl)-1H-indol-3-yl]-ethyl}-carbamic  






H NMR of methyl-{2-[4-(3-methyl-buta-1,3-dienyl)-1H-indol-3-yl]-ethyl}- 













H NMR of {3-[2-(3-methyl-buta-1,3-dienyl)-6-nitro-phenyl]-but-3-enyl}-






H NMR (75 oC) of 5-methylene-1-(2-methyl-propenyl)-6-nitro-1,3,4,5-






C NMR (65 oC) of 5-methylene-1-(2-methyl-propenyl)-6-nitro-1,3,4,5-






H NMR of 6-(2-methyl-propenyl)-3,4-dihydro-1H,6H-azepino[5,4,3- 






C NMR of 6-(2-methyl-propenyl)-3,4-dihydro-1H,6H-azepino[5,4,3- 






H NMR of 3-[2-(3-methoxycarbonylamino-1-methylene-propyl)-3-nitro- 




Figure 115: 13C NMR of 3-[2-(3-methoxycarbonylamino-1-methylene-propyl)-3-nitro-






H NMR of 3-[3-(2-methoxycarbonylamino-ethyl)-1H-indol-4-yl]-acrylic acid 






C NMR of 3-[3-(2-methoxycarbonylamino-ethyl)-1H-indol-4-yl]-acrylic acid 






H NMR of {2-[4-(3-hydroxy-3-methyl-but-1-enyl)-1H-indol-3-yl]-ethyl}-






C NMR of {2-[4-(3-hydroxy-3-methyl-but-1-enyl)-1H-indol-3-yl]-ethyl}-

















H NMR of acetic acid 2-(2-bromo-allyl)-1,4-dimethyl-5-oxo-pyrrolidin- 






C NMR of acetic acid 2-(2-bromo-allyl)-1,4-dimethyl-5-oxo-pyrrolidin- 












Figure 125: 1H NMR of acetic acid 2-{2-[2-(4-methoxy-benzyloxy)-6-nitro-phenyl]- 











































































Figure 131: 13C NMR of 3-methyl-1-(1-phenyl-ethyl)-1,5-dihydro-pyrrol-2-one (93) 
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 Figure 132: 
1





Figure 133: 1H NMR of 5-(2-bromo-allyl)-3-methyl-1-(1-phenyl-ethyl)-1,5-dihydro- 





Figure 134: 13C NMR of 5-(2-bromo-allyl)-3-methyl-1-(1-phenyl-ethyl)-1,5-dihydro- 

















Figure 137: 1H NMR (65 oC) of trifluoro-methanesulfonic acid 2-{1-[4-methyl-5-oxo-1-(1-
phenyl-ethyl)-2,5-dihydro-1H-pyrrol-2-ylmethyl]-vinyl}-3-nitro-phenyl ester (98)

